欧洲药典7.4索引(现行版)

更新时间:2023-09-05 11:12:01 阅读量: 教育文库 文档下载

说明:文章内容仅供预览,部分内容可能不全。下载后的文档,内容与下面显示的完全一致。下载之前请确认下面内容是否您想要的,是否完整无缺。

欧洲药典7.4索引(现行版)

EUROPEANPHARMACOPOEIA

http://www.77cn.com.cn/forum.php?mod=viewthread&tid=21456&fromuid=1023 7.4

INDEX

Toaiduserstheindexincludesareferencetothesupplementinwhichthelatestversionofatextcanbefound.

Forexample:Amikacinsulfate...............................................7.1-3377

meansthemonographAmikacinsulfatecanbefoundonpage3377ofSupplement7.1.

Notethatwherenoreferencetoasupplementismade,thetextcanbefoundintheprincipalvolume.

Englishindex........................................................................4401Latinindex.................................................................................4433GeneralNotices(1)applytoallmonographsandothertexts4399

欧洲药典7.4索引(现行版)

http://www.77cn.com.cn/forum.php?mod=viewthread&tid=21456&fromuid=1023 EUROPEANPHARMACOPOEIA

7.4

4400Seetheinformationsectionongeneralmonographs(coverpages)

欧洲药典7.4索引(现行版)

EUROPEANPHARMACOPOEIAhttp://www.77cn.com.cn/forum.php?mod=viewthread&tid=21456&fromuid=1023 7.4

IndexNumerics2.2.64.

1.spectrometry..........................................................................Peptideidentificationbynuclearmagneticresonance7.2-3531

2.1.1.GeneralDroppers...................................................................................notices...................................................................7.4-4083152.2.6.2.2.7.Refractive

http://www.77cn.com.cnparativetableofporosityofsintered-glass2.2.8.OpticalViscosity....................................................................................rotation.......................................................................index......................................................................262627

2.1.4.UltravioletSieves.........................................................................................16raylampsforanalyticalpurposes...................filters...15152.2.9.

2.1.5.2.2.Capillary

2.1.6.Tubesforcomparativetests..................................................172.3.1.Physicalviscometermethod...............................................27

Identificationandphysicochemicalreactionsofionsmethods.................................21andfunctionalgroups..107

2.1.Apparatus....................................................................................Gasdetectortubes...................................................................17152.3.2.Identificationoffattyoilsbythin-layerchromato-

2.2.10.2.2.11.Viscosity2.3.3.graphy..............................................................................................Identificationofphenothiazinesbythin-layer110

2.2.12.Distillation-Rotating

Boilingpoint..........................................................................31range..................................................................viscometermethod..........................2830

2.2.13.2.3.4.chromatography.............................................................................110

2.2.14.Determination2.3.Identification.............................................................................Odour......................................................................................110107

2.2.15.Meltingofwaterbydistillation..............................31

Meltingpointpoint--capillaryopencapillarymethod........................................31method............................322.4.10.

2.2.16.2.4.11.Leadinsugars......................................................................117

2.2.17.2.4.12.Phosphates............................................................................117Potassium..............................................................................117

2.2.18.DropMelting

Freezingpoint..............................................................................point-instantaneousmethod............................32

point.......................................................................32342.4.13.

2.2.19.2.4.14.Sulfates........................................................................

2.2.1.2.4.14.SulfatedSulfatedash.........................................................................7.3-3781

ash(5.8.).....................................................7.1-3346118

2.2.20.ClarityAmperometric

Potentiometricanddegreetitration.......................................................34

titration......................................................ofopalescenceofliquids.....................21342.4.15.

2.2.21.2.4.16.Nickelinpolyols.................................................................118

2.2.22.Fluorimetry............................................................................2.4.17.Aluminium............................................................................Totalash...............................................................................118118

2.2.23.AtomicAtomicemissionabsorptionspectrometry..........................................35

spectrometry......................................35362.4.18.

2.2.24.2.4.19.Freeformaldehyde.............................................................118

2.2.25.Absorptionspectrophotometry,infrared........................382.4.1.Ammonium.............................................................................Alkalineimpuritiesinfattyoils.......................................119113

visible..................................................................................................Absorptionspectrophotometry,ultravioletand402.4.21.Foreignoilsinfattyoilsby

2.2.26.2.2.27.Paper2.4.22.graphy..............................................................................................thin-layerchromato-

Compositionoffattyacidsbygaschromatography...119119

2.2.28.Thin-layerchromatography........................................................41

Gaschromatography...........................................................chromatography................................................42432.4.23.Sterolsinfattyoils....................................................7.2-3535

2.2.29.2.4.24.

2.2.2.2.4.25.IdentificationEthyleneoxideandandcontroldioxan...............................................ofresidualsolvents...7.2-3537127

2.2.30.DegreeLiquid

Size-exclusionofchromatography......................................................colorationchromatography........................................ofliquids............................................4522462.4.26.

2.2.31.2.4.27.N,N-Dimethylaniline..........................................................128

2.2.31.Electrophoresis.....................................................................2.4.28.Heavy2-Ethylhexanoicmetalsinherbalacid.........................................................drugsandfattyoils.................129130

2.2.32.ElectrophoresisLossondrying.......................................................................51(5.8.)................................................7.1-334546

http://www.77cn.com.cnpositionoffattyacidsinoilsrichinomega-3

2.2.33.2.2.34.Nuclear2.4.2.acids..................................................................................................Arsenic....................................................................................130113

2.2.35.Thermalmagneticresonancespectrometry....................52

Osmolality...................................................................analysis...................................................................7.3-3777542.4.30.Ethyleneglycolanddiethyleneglycolin

2.2.36.Potentiometricdeterminationofionic2.4.31.substances.......................................................................................ethoxylated

Nickelinhydrogenatedvegetableoils...........................132132

2.2.37.concentrationX-rayfluorescenceusingion-selectivespectrometry.......................................electrodes.............................57582.4.32.

2.2.38.2.4.3.

2.2.39.Conductivity..........................................................................2.4.4.Calcium...................................................................................Totalcholesterolinoilsrichinomega-3acids............133

Chlorides................................................................................113113

2.2.3.PotentiometricMolecularmassdeterminationdistributioninofdextrans........................59

pH..................................60242.4.5.

2.2.40.2.4.6.Fluorides.................................................................................114

2.2.41.Near-infrared2.4.7.Magnesium..............................................................................114Magnesiumandalkaline-earthmetals..............................114

2.2.42.CircularDensityofdichroism................................................................spectrophotometry......................................61

solids...................................................................65662.4.8.

2.2.43.2.4.9.Heavymetals..........................................................................114

2.2.44.Mass2.4.LimitIron...........................................................................................117tests..................................................................................113

http://www.77cn.com.cnaniccarboninwaterforpharmaceutical67

692.5.10.

2.2.45.2.5.11.Oxygen-flask

http://www.77cn.com.cnplexometricmethod.........................................................139

Water:semi-microtitrations................................................determination...................................140140

2.2.47.ChromatographicCapillaryelectrophoresisseparation(5.8.)...............................techniques........................7.1-3345702.5.13.

2.2.47.2.5.14.Aluminiuminadsorbedvaccines.....................................141

2.2.48.Capillaryelectrophoresis.........................................7.1-33132.5.15.CalciumPhenolininimmunoseraadsorbedvaccines..........................................141andvaccines..............................141

2.2.49.RamanFallingspectrometry...........................................................ballviscometermethod.........................................82832.5.16.

2.2.4.Relationshipbetweenreactionofsolution,approximatepH2.5.17.Proteininpolysaccharidevaccines.................................141

2.5.18.NucleicPhosphorusacidsininpolysaccharidepolysaccharidevaccines........................vaccines......................142142

2.2.54.andcolourIsoelectricofcertainfocusing..............................................................indicators...................................................25832.5.19.

2.2.54.2.5.1.

2.2.55.Isoelectricfocusing(5.8.)........................................7.1-33452.5.20.AcidO-Acetyl

Hexosaminesvalue...............................................................................inpolysaccharidevaccines...............................142

inpolysaccharidevaccines......................137142

2.2.55.PeptidePeptidemapping...................................................................mapping(5.8.).............................................7.1-3345852.5.21.

2.2.56.2.5.22.Methylpentosesinpolysaccharidevaccines.................

2.2.56.Amino2.5.23.UronicSialicacidacidsininpolysaccharidepolysaccharidevaccines...........................vaccines.......................143143143

2.2.57.Aminoacid

Inductivelyacidanalysis.............................................................analysis88

coupled(5.8.)........................................plasma-atomicemission7.1-33452.5.24.2.5.25.Carbon

2.2.58.spectrometry.....................................................................................942.5.26.Carbondioxideingases....................................................143

Nitrogenmonoxidemonoxideinandgases...............................................nitrogendioxideingases.....144145

2.2.59.InductivelyGlycananalysiscoupledofglycoproteins.......................................plasma-massspectrometry............96972.5.27.

2.2.5.2.5.28.Oxygen

2.2.60.RelativeMeltingdensity.......................................................................point-instrumentalmethod.............................102252.5.29.WaterSulfurinin

dioxide.....................................................................gases.....................................................................gases..................................................................1451451452.5.2.2.5.30.EsterOxidisingvalue.............................................................................substances.........................................................137146

GeneralNotices(1)applytoallmonographsandothertexts4401

欧洲药典7.4索引(现行版)

Indexhttp://www.77cn.com.cn/forum.php?mod=viewthread&tid=21456&fromuid=1023 EUROPEANPHARMACOPOEIA

7.4

2.5.31.2.7.22.2.5.32.RiboseWater:inmicropolysaccharidedetermination............................................vaccines..................................1461462.7.23.AssayNumerationofhumanofCD34/CD45+coagulationfactorcellsXI...........................227inhaemato-2.5.33.2.5.34.Total2.7.24.poietic

2.5.35.Aceticprotein........................................................................

Nitrousacidoxideinsynthetic147

ingases.......................................................peptides....................................1501502.7.25.Flowproducts.............................................................................228

Assaycytometry...................................................................229ofhumanplasmininhibitor..................................2302.5.36.2.7.27.2.5.37.Anisidinevalue...................................................................150

methanesulfonicMethyl,ethylacid...........................................................andisopropylmethanesulfonatein7.1-33212.7.28.andtoxoidsFlocculation

Colony-forming(Ramonvalueassay)..........................................................(Lf)ofdiphtheriaandtetanustoxins

cellassayforhumanhaematopoietic231pro-2.5.38.Methyl,ethyl2.7.29.genitor

2.5.39.substances..............................................................................andisopropylmethanesulfonateinactive

Methanesulfonylchlorideinmethanesulfonic7.3-37852.7.2.MicrobiologicalNucleatedcells.....................................................................................232cellcountassayofandantibiotics.........................viability...................................2337.3-37892.7.30.2.5.3.acid...........................................................................................2.7.31.Assay

2.5.4.HydroxylIodinevalue...........................................................................value......................................................................7.4-40931371372.7.32.AssayofhumanproteinC................................................234

Assayofofhumanhumanproteinα-1-proteinaseS.................................................235inhibitor......................2362.5.5.2.7.4.2.5.6.Peroxide2.7.5.Assay

2.5.7.Saponificationvalue.......................................................................

Unsaponifiablevalue............................................................138

matter.........................................................1391392.7.6.AssayofhumancoagulationfactorVIII..........................207

Assayofofheparin....................................................................208diphtheriavaccine(adsorbed)...........................2092.5.8.2.7.7.2.5.9.Determinationof2.7.8.Assayofpertussisvaccine

2.5.Assays.........................................................................................Determinationofprimarynitrogenaromaticbysulfuricamino-nitrogen....aciddigestion..1391391372.7.9.Assayoftetanusvaccine(adsorbed).................................(wholecell)...................7.2-3549214TestforFcfunctionofimmunoglobulin..........................2172.6.10.2.6.11.Histamine.............................................................................1622.7.

2.6.12.DepressorMicrobiologicalsubstances........................................................examinationofnon-sterileproducts:1622.8.10.Biological

2.8.11.Solubilityassays......................................................................

Assayof1,8-cineoleinalcoholinof201

essentialessentialoils..............................240oils.............................240

2.6.12.microbialenumerationtests........................................................1632.8.12.

microbialMicrobiologicalenumerationexaminationtests(5.8.)....................................ofnon-sterileproducts:7.1-33462.8.13.Determinationofessentialoilsinherbaldrugs..........241

2.8.14.PesticideDeterminationresidues...............................................................242oftanninsinherbaldrugs....................2432.6.13.2.8.15.

2.6.13.forspecifiedMicrobiologicalexaminationofnon-sterileproducts:test

Microbiologicalmicro-organisms.....................................................examinationofnon-sterileproducts:167test2.8.16.Bitternessvalue..................................................................244

2.8.17.LossDryresidueondryingofextracts......................................................244ofextracts................................................244

2.6.14.forspecifiedmicro-organisms2.8.18.

2.6.15.BacterialPrekallikreinendotoxins..........................................................(5.8.)..................................7.1-3346

activator.......................................................1711752.8.1.DeterminationofaflatoxinB1inherbaldrugs............244

2.6.16.Testsforextraneousagentsinviralvaccines2.8.20.AshHerbalinsolubledrugs:insamplinghydrochloricandacid...................................239samplepreparation........2462.8.21.

http://www.77cn.com.cne....................................................................................................forhuman

Testforanticomplementaryactivityof1762.8.22.Test

2.8.23.Determinationforaristolochic

Microscopicexaminationofochratoxinacidsinherbal

ofherbalAinherbaldrugs...................247

drugs....................250drugs..........249

2.6.18.immunoglobulin.............................................................................2.8.2.

2.6.19.TestTestforforneurovirulenceneurovirulenceofoflivepoliomyelitisvirusvaccines..............177

vaccine1792.8.3.Foreign

2.8.4.Stomatamatter......................................................................239

Swellingandindex.......................................................................239stomatalindex..............................................239

2.6.1.(oral).................................................................................................2.8.5.

2.6.1.SterilitySterility..........................................................................(5.8.)................................................................7.1179

7.1-3346-33252.8.6.Water

2.6.20.2.8.7.Foreignin

Fattyoilsestersessentialoils..........................................................239

andresinifiedinessentialessentialoils..........................................239oilsinessentialoils..239

2.6.21.Anti-Aandanti-Bhaemagglutinins.......................7.2-35452.8.8.

2.6.22.NucleicActivatedacidcoagulationamplificationfactors..........................................techniques...........................1811852.8.9.Odour

2.6.24.Avianviralvaccines:testsforextraneousagents2.8.MethodsResidueand

inontaste

pharmacognosy..................................................239evaporationofessentialofessentialoils.......................................240oils.........................240

2.9.10.

2.6.25.seedlots...........................................................................................in

Avianlivevirusvaccines:testsforextraneousagents185in2.9.11.Ethanol

2.9.12.Testcontentandalcoholimetrictables..................268

Sievefortest..............................................................................270methanoland2-propanol..................................270

2.6.26.batchesoffinishedproduct.........................................................1882.9.14.

lin.............................................................................................Testforanti-Dantibodiesinhumanimmunoglobu-7.2-35462.9.16.Specificsurfaceareabyairpermeability......................271

2.6.27.2.9.17.Flowability............................................................................272Testforextractablevolumeofparenteral

2.6.2.Microbiologicalcontrol

2.6.30.Mycobacteria.........................................................................ofcellularproducts................191

Monocyte-activationtest...................................................1561922.9.17.preparations....................................................................................273

2.6.31.Microbiological(5.8.).........................................................................................Testforextractablevolumeofparenteralpreparations7.1-33462.9.18.Preparationsfor

2.6.7.productsMycoplasmas..........................................................................fororaluse.....................................................................examinationofherbalmedicinal1971562.6.8.2.9.19.fineparticles...................................................................................inhalation:aerodynamicassessment

Particulatecontamination:sub-visibleparticles274of

2.6.9.Pyrogens.................................................................................161

2.6.BiologicalAbnormaltests.........................................................................toxicity.................................................................1621532.9.19.(5.8.).........................................................................................7.1

2.7.10.particles..................................................................................Particulatecontamination:sub-visible-3347

7.1-3333

2.7.11.Assayofhuman2.9.1.

2.7.12.AssayAssayofofhumancoagulation

heparincoagulationfactor

incoagulationfactorVII.........................

factors........................220IX...........................2192192.9.1.Disintegrationoftabletsand

2.7.13.2.9.20.DisintegrationParticulatecontamination:oftabletsandcapsules

visiblecapsules....................(5.8.).........7.1

particles................2877.1-3346-3331

2.7.14.Assayofhumananti-Dimmunoglobulin.......................2202.9.22.Softeningtimedeterminationof

2.7.15.AssayAssayofofhepatitishepatitisABvaccine.............................................222vaccine(rDNA)......................7.3-37942.7.16.2.9.23.suppositories...................................................................................288lipophilic

Gaspycnometricdensityofsolids..................................288

2.7.17.Assayofpertussisvaccine(acellular).............................2232.9.25.

2.7.18.AssayAssayofofhumanhumanantithrombincoagulationfactorIII....................................224II............................2242.9.26.Dissolutiontestformedicatedchewinggums....7.4-4097

2.7.19.2.9.26.SpecificSpecificsurfacesurfaceareaareabybygasgasadsorption........................adsorption(5.8.)....7.1-3347291

2.7.19.AssayofhumancoagulationfactorX............................2252.9.27.Uniformityofmassofdelivereddosesfrommultidose

2.7.1.ImmunochemicalAssayofhumancoagulationmethods.................................................factorX(2.7.19.).............2252012.7.20.2.9.29.containers........................................................................................294Intrinsicdissolution...........................................................294

2.7.21.InAssayvivoofassayhumanofpoliomyelitisvonWillebrandvaccinefactor..........................226(inactivated)....2252.9.2.2.9.31.DisintegrationParticlesizeanalysisofsuppositoriesbylaserlightandpessaries...............255diffraction............2954402Seetheinformationsectionongeneralmonographs(coverpages)

欧洲药典7.4索引(现行版)

EUROPEANPHARMACOPOEIAhttp://www.77cn.com.cn/forum.php?mod=viewthread&tid=21456&fromuid=1023 7.4

Index

2.9.32.3.2.8.porosimetry.....................................................................................299Porosityandpore-sizedistributionofsolidsbymercury3.2.9.SterileRubbersingle-useclosuresforplasticcontainerssyringes.....................................373foraqueous2.9.33.parenteral

2.9.34.solidsCharacterisationbyBulkX-rayofcrystallineandpartiallycrystalline

densitypowderanddiffractiontappeddensity(XRPD)...............................ofpowders...............3053013.2.freeze-driedpreparations,

Containers.................................................................................363powders.....................................................................forpowdersandfor374

2.9.35.3-2.9.36.Powderfineness.................................................................3084.1.1.O-Desacyl-4′-monophosphoryllipidA.............................7.2-3639

2.9.36.PowderPowderflow.........................................................................308flow(5.8.).....................................................7.1-33474.1.2.Reagents........................................................................Standardsolutionsforlimittests.............................7.47.4-4109-42162.9.37.2.9.37.Optical4.1.3.

2.9.38.Opticalmicroscopy..............................................................311

Particle-sizemicroscopydistribution(5.8.).........................................estimationbyanalytical7.1-33474.1.Buffer

4.2.1.Reagents,solutions...........................................................

Primarystandardstandardssolutions,forvolumetricbuffersolutions..........solutions........7.4

7.47.4-4220

-4225-4109

2.9.38.sieving..............................................................................................4.2.2.

(5.8.).........................................................................................Particle-sizedistributionestimationbyanalytical313

7.1sieving-33474.2.4-AminobenzoicVolumetricVolumetricanalysis.........................................................solutions...................................................7.4-4225

acid.....................................................................13717.4-4225

2.9.39.4.

2.9.3.sorption-desorptionWater-solidinteractions:

Dissolutiontestisothermsforsoliddosageanddeterminationofwaterforms..................activity....of7.17.3-3335-37975.10.Reagents...............................................................................

use............................................................................................Controlofimpuritiesinsubstancesforpharmaceutical7.4-4109

7.4-42472.9.40.2.9.41.Uniformityofdosageunits......................................5.1.10.

2.9.42.FriabilityDissolutionofgranules7.4-4101

testforlipophilicandspheroids.....................soliddosageforms.......7.4-41033195.11.Guidelinesforusingthetestfor

5.1.1.CharactersMethodsofsectionpreparationinmonographs....................................637bacterialendotoxins..520

ofsterileproducts....................5032.9.43.2.9.44.Apparent5.1.2.

3803Preparationsdissolution.........................................................320fornebulisation:characterisation.........7.3-5.12.Biologicalindicatorsofsterilisation.................................504

5.1.3.ReferenceEfficacyofstandards..............................................................antimicrobialpreservation.............................505641

2.9.45.2.9.4.Wettabilityofporoussolidsincludingpowders..........3215.14.

2.9.5.DissolutionUniformityoftestmassforoftransdermalsingle-dosepatches........................263preparations.............2655.1.4.Gene

preparationsMicrobiologicaltransfermedicinal

andsubstancesqualityproductsofforhumanuse..........647

fornon-sterilepharmaceuticalpharmaceuticaluse...........5072.9.6.2.9.7.Uniformityofcontentofsingle-dosepreparations........2665.1.4.

2.9.7.FriabilityFriabilityofofuncoateduncoatedtablets.............................................266tablets(5.8.)..........................7.1-3346preparationsMicrobiologicalqualityof

(5.8.).........................................................................................andsubstancesfornon-sterilepharmaceuticalpharmaceuticaluse7.1-33472.9.8.2.9.9.Resistancetocrushingoftablets......................................2675.1.5.ApplicationoftheF0concepttosteam

2.9.PharmaceuticalMeasurementoftechnicalconsistencyprocedures.................................253bypenetrometry..............267

3.1.10.Materialsbasedon5.15.aqueoussterilisationof

Functionality-relatedpreparations...................................................................508characteristicsofexcipients.........6615.1.6.Alternativemethodsforcontrolof

3.1.11.forcontainersMaterialsforbasednon-injectable,non-plasticisedpoly(vinylchloride)

onnon-plasticisedaqueouspoly(vinylsolutions............349chloride)for5.16.quality...............................................................................................508microbiological

Crystallinity....................................................................7.4-4253

3.1.1.1.containers5.17.1.

containersMaterialsfordrydosageformsfororaladministration......350

forhumanbasedbloodonplasticisedandbloodpoly(vinylcomponents.............329chloride)for5.17.

3.1.1.2.testing...............................................................................................665RecommendationsRecommendationsononmethodsdissolutionfortesting.....................665dosageformstubingMaterials5.1.7.

components.....................................................................................332usedinsetsbasedforontheplasticisedtransfusionpoly(vinylofbloodchloride)andbloodfor5.1.8.Viral

3.1.13.oraluse............................................................................................Microbiologicalsafety..............................................................................qualityofherbalmedicinalproductsfor518

519

3.1.14.Plastic5.1.9.

containersMaterialsadditives..................................................................352

foraqueousbasedonsolutionsplasticisedforpoly(vinylintravenouschloride)infusion..355for5.1.Guidelinesforusingthetestforsterility........................519

3.1.15.5.2.1.GeneralTerminologytextsonusedmicrobiology..............................................503inmonographsonbiological

3.1.1.preparationsPolyethyleneterephthalateforcontainersfor

Materialsnotforforcontainersparenteralforuse...........................................357humanbloodandblood5.2.2.products...........................................................................................527

productionChickenandflocksqualityfreecontrolfromspecifiedofvaccines.............................527pathogensforthe

http://www.77cn.com.cnponents.....................................................................................3295.2.3.

http://www.77cn.com.cne.....................................................................................................530Cellsubstratesfortheproductionofvaccinesforhuman

Cellculturesfortheproductionofveterinary

3.1.5.parenteral

preparationsPolyethylenepreparations

andforwithophthalmicadditivesandforophthalmicforpreparations...337

preparations.......................338containersforparenteral5.2.5.vaccines............................................................................................533

3.1.6.PolypropyleneforcontainersandimmunologicalSubstancesveterinaryofanimalmedicinaloriginforproducts........................535theproductionof

5.2.6.Evaluationofsafetyofveterinaryvaccinesand

3.1.7.preparationsPoly(ethyleneandophthalmicclosuresforparenteral

-vinylacetate)preparations..............................342forcontainersandtubingfor5.2.7.immunoseraEvaluation...................................................................................536ofefficacyofveterinaryvaccinesand

3.1.8.total

3.1.9.Siliconeparenteral

Siliconeoilnutrition

elastomerusedaspreparations.....................................345

foralubricant.........................................347closuresandtubing....................3475.2.8.immunosera....................................................................................538

3.1.encephalopathyMinimisingagentstheriskviaofhumantransmittingandveterinaryanimalspongiformmedicinal

3.2.1.Materialsusedfor

3.2.2.1.Glassthemanufactureofcontainers...........329

Plasticcontainerscontainersforpharmaceuticalforaqueoussolutionsuse........................363for5.2.9.products..................................................................................

andimmunosera............................................................................547Evaluationofsafetyofeachbatchofveterinaryvaccines7.4-4233

3.2.2.infusion............................................................................................3685.2.

use.....................................................................................................368Plasticcontainersandclosuresforpharmaceutical5.3.General

3.2.3.Sterileplasticcontainersforhumantests...................................................................................................Statisticaltextsanalysisonbiologicalofresultsproducts...................................527ofbiologicalassaysand5515.4.

3.2.4.bloodbloodand

Emptycomponents.........................................................................369sterilecontainersofplasticisedpoly(vinylchloride)5.5.Residualsolvents.....................................................................583

5.6.AlcoholimetricAssayofinterferons.................................................................607tables..............................................................593

3.2.5.forhumanSterilebloodcontainersandbloodcomponents.................................3705.7.Tableofphysicalcharacteristicsofradionuclides

humanbloodcontainingofanticoagulantplasticisedpoly(vinylsolution...................chloride)for3713.2.6.5.8.inthePharmacopoeialEuropeanPharmacopoeia...............................................mentioned

harmonisation..................................7.1-3345611

components.....................................................................................Setsforthetransfusionofbloodandblood3715.9.Polymorphism...........................................................................627GeneralNotices(1)applytoallmonographsandothertexts4403

欧洲药典7.4索引(现行版)

Indexhttp://www.77cn.com.cn/forum.php?mod=viewthread&tid=21456&fromuid=1023 EUROPEANPHARMACOPOEIA

7.4Aall-

AbbreviationsAlmagate..........................................................................................1345rac-α-Tocopherylacetate.................................................7.2-3720Abnormaltoxicityand(2.6.9.)...............................................................symbols(1.)............................................7.4-4083162Almond

AbsorptionAlmondoil,

Absorptionspectrophotometry,infrared(2.2.24.)......................Aloes,Barbados..............................................................................1047oil,refined........................................................................1346virgin..........................................................................1347

(2.2.25.)..............................................................................................spectrophotometry,ultravioletandvisible38

40Aloes,

Acacia................................................................................................1043Aloes

Acacia,Alphacyclodextrin...................................................................dryCape......................................................................................1048extract,standardised...................................................10497.3-3889Acamprosatespray-dried.........................................................................calcium....................................................................13011301Alprazolam......................................................................................1347AcanthopanaxAlprenolol

Acarbose...........................................................................................1302bark................................................................7.3-3855Alprostadil.......................................................................................1350hydrochloride.............................................................1349Acebutololhydrochloride.............................................................1304Alteplase

Aceclofenac......................................................................................1306Alternativeforinjection............................................................7.3-3890Acemetacin......................................................................................1307(5.1.6.)...............................................................................................508methodsforcontrolofmicrobiologicalqualityAcesulfamepotassium..................................................................1309Altizide.............................................................................................1356AcetateAlum..................................................................................................1357Acetazolamide.................................................................................trihydrate,sodium...........................................................2908Aluminium(2.4.17.).........................................................................118Aceticacid,glacial.........................................................................13101311Aluminium

AceticAluminiumchloride

Acetone.............................................................................................acidinsyntheticpeptides(2.5.34.)..................................150Aluminiumhydroxide,hexahydrate...............................................1357

inadsorbedhydrated,vaccinesfor(2.5.13.)...................................141adsorption.....................1357

Acetylcholinechloride..................................................................13121313Aluminium

Acetylcysteine.................................................................................Aluminiummagnesiumsilicate...................................................1358β1313Aluminiumoxide,phosphatehydrated..........................................................1359gel............................................................1360Acetylsalicylic-Acetyldigoxin...............................................................................acid.........................................................................13151317Aluminium

Acetyltryptophan,Aluminiumphosphate,hydrated................................................1361Acetyltyrosine,Aluminiumsodiumsulfate..........................................................................1362silicate..........................................................1361Aciclovir...........................................................................................1321N-....................................................................N-.....................................................................7.2-36051319

Alverine

AcidAmantadinecitrate...............................................................................1363Acitretin............................................................................................1323value(2.5.1.).............................................................................137Ambroxolhydrochloride...............................................................1365hydrochloride..........................................................1364Actinobacillosisvaccine(inactivated),porcine..........................926Amfetamine

ActivatedAmidotrizoate,sulfate........................................................................1366Activatedcharcoal..........................................................................1649Amidotrizoicacidsodium..................................................................dihydrate.........................................................13662910Adapalene........................................................................................1324coagulationfactors(2.6.22.)........................................185Amikacin..........................................................................................1367Additives,Amikacin

Adenine............................................................................................1326plastic(3.1.13.)...............................................................352Amiloridesulfate......................................................................hydrochloride...............................................................13707.1-3377Adeno-associated-virusvectorsforhumanuse.........................656Amino

Adenosine........................................................................................1327Aminoacid

AdipicAminobenzoicacidanalysisanalysis(2.2.56.)...........................................................88

acid,4-...................................................................1371(2.2.56.)(5.8.).....................................7.1-3345

Adrenaline.......................................................................................1329acid.......................................................................................1328Aminocaproic

AdrenalineAminoglutethimide........................................................................1373acid.........................................................................1373Adsorption,tartrate........................................................................1330Aminophylline,anhydrous...........................................................3068Adsorption,gas,gas,specificspecificsurfacesurfaceareaareabyby(2.9.26.)....................(2.9.26.)291AminophyllineAminosalicylatehydrate..................................................................3069Aerodynamic(5.8.).........................................................................................Amiodaronehydrochloride..........................................................1375dihydrate,sodium............................................2911inhalation(2.9.18.)........................................................................assessmentoffineparticlesinpreparations7.1for-3347

274Amisulpride.....................................................................................1376

AflatoxinBAmitriptyline

Agar...................................................................................................10441inherbaldrugs,determinationof(2.8.18.).........244Amlodipinebesilate................................................................hydrochloride........................................................13777.4-4275Agnuscastusfruit..........................................................................1044Ammonia(13

Agrimony.........................................................................................1046Ammonia

Air,Ammoniosolution,N)injection.................................................................965

methacrylateconcentrated...............................................1380copolymer(typeA)............................1381

Air,medicinal..................................................................................1331syntheticmedicinal................................................................1333Ammonio

Alanine.............................................................................................1334Ammoniummethacrylate

Albendazole.....................................................................................1335Ammonium(2.4.1.)..........................................................................copolymer(typeB)............................1382

bromide......................................................................1382113

Albuminsolution,human.............................................................2165Ammonium

Alchemilla........................................................................................1047Ammoniumchloride......................................................................1383AlcoholimetricAmmoniumglycyrrhizate.............................................................1384hydrogencarbonate................................................1385Alcoholimetrictablestables(2.9.10.)......................................................268(5.5.)............................................................593Amobarbital.....................................................................................1385AlcuroniumAmobarbital

Alendronate,chloride......................................................................1336Amoxicillinsodium........................................................................1386sodium......................................................................1386Alexandriansennasodium.....................................................................2908pods...............................................................1238Amoxicillin

Alfacalcidol...............................................................................Amperometrictrihydrate...................................................................1389Alfadex.......................................................................................7.2-3606AmphotericinB..............................................................................titration(2.2.19.).....................................................139134Alfentanilhydrochloride...............................................................13397.3-3889Ampicillin,

AlfuzosinAmpicillin

Alginate,hydrochloride...............................................................1341Ampicillinsodium..........................................................................1395anhydrous..................................................................1393

trihydrate.....................................................................1397

Alginicacid......................................................................................1342sodium.............................................................................2909Amylmetacresol..............................................................................1399Alkaline-earthAnaemia

AlkalineAnaestheticvaccineether...........................................................................1968(live),chicken,infectious................................910Allantoin...........................................................................................1342impuritiesmetalsinandfattymagnesiumoils(2.4.19.).....................................(2.4.7.)...........................114119Analysis,

AllergenAnalyticalthermal(2.2.34.)................................................................Allopurinol.......................................................................................1343products....................................................................7.3-3813(2.9.38.)............................................................................................sieving,particle-sizedistributionestimationby54

313

all-rac-α-Tocopherol................................................................7.2-3718Analytical(2.9.38.)(5.8.)........................................................................sieving,particle-sizedistributionestimationby7.1-33474404Seetheinformationsectionongeneralmonographs(coverpages)

欧洲药典7.4索引(现行版)

EUROPEANPHARMACOPOEIAhttp://www.77cn.com.cn/forum.php?mod=viewthread&tid=21456&fromuid=1023 7.4

IndexAngelicaAngelicadahuricapubescensroot...........................................................root........................................................7.37.3-3855-3857AssayAssayofofhepatitishepatitisABvaccinevaccine(2.7.14.)...........................................222(rDNA)(2.7.15.)...................7.3-3794AngelicaAnimalAssay

Animalanti-Troot...................................................................................1049

immunoseralymphocyteforhumanimmunoglobulinuse.............................................678forhumanuse..1404Assayofhumananti-Dimmunoglobulin(2.7.13.).....................220

AssayofofhumanhumanantithrombincoagulationfactorIII(2.7.17.)..................................224II(2.7.18.)..........................224Animalspongiformencephalopathies,productswithriskAssay

Animaltransmittingspongiformagentsencephalopathyof...................................................................686of

agents,minimisingtheriskAssayofhumancoagulationfactorIX(2.7.11.).........................219

AssayofofhumanhumancoagulationcoagulationfactorfactorVIIVIII(2.7.10.).......................(2.7.4.)........................207219

oftransmittingviahumanandAssay

Aniseed......................................................................................(5.2.8.).....................................................................................veterinarymedicinalproducts7.47.3-4233-3858AssayofhumancoagulationfactorX

Assayofofhumanhumancoagulationplasmininhibitorfactor(2.7.25.)................................230XI(2.7.19.)..........................225(2.7.22.)........................227

AniseAnisidineoil............................................................................................1050Assay

Antazolinevaluehydrochloride.............................................................(2.5.36.).................................................................1401150Assayof

AssayofhumanproteinC(2.7.30.)..............................................234

ofhumanhumanproteinvonWillebrandS(2.7.31.)...............................................235factor(2.7.21.).......................226AnthraxAnthraxsporeAssay

culturevaccinevaccine

filtrates).............................................................................forhuman(live)useforveterinary(adsorbed,use.........................847preparedfrom745Assayof

Assayofinterferons

ofpertussispertussisvaccine(5.6.)..............................................................607

vaccine(acellular)(wholecell)(2.7.16.)..........................223(2.7.7.).................7.2-3549Anti-AAntibiotics,andanti-Bhaemagglutinins(2.6.20.).....................7.2-3545Assay

Antibodies(anti-D)microbiologicalinhumanassayimmunoglobulin,of(2.7.2.).....................testfor7.3-3789Assayof

Assaysofpoliomyelitis

(2.5.).......................................................................................tetanusvaccinevaccine(adsorbed)(inactivated),(2.7.8.)..............................invivo(2.7.20.)..225

137214

Antibodies(2.6.26.)...................................................................................Astragalus

Anticoagulantforhumanandpreservativeuse,monoclonal.............................7.2-3546

solutionsforhumanblood7.3-3815Atenolol............................................................................................1424mongholicusroot......................................................1060

Atomicabsorptionspectrometry(2.2.23.)....................................36

Anticomplementary.........................................................................................................Atomic

Anti-Dantibodiesinactivityhumanofimmunoglobulin,immunoglobulintest(2.6.17.).......1401

for177Atomicemissionspectrometry(2.2.22.)........................................35

(2.2.57.)..............................................................................................emissionspectrometry,inductivelycoupledplasma-94

Anti-D(2.6.26.)...................................................................................Atorvastatin

human............................................................................................immunoglobulinforintravenousadministration,7.2-3546

2167Atracuriumcalciumtrihydrate...........................................7.1-3380

Atropine...........................................................................................1427besilate.......................................................................1425

Anti-DAnti-Dimmunoglobulin,Atropine

Antimicrobialimmunoglobulin,human.................................................

preservation,human,efficacyassay2166

of(5.1.3.)..........................505of(2.7.13.)...................220Aujeszky’ssulfate..............................................................................1429

Aujeszky’sdiseasediseasevaccinevaccine(inactivated)(live)forpigsforforpigs......................847parenteralAntiserum,AntithrombinEuropeanvipervenom..............................................953

AntithrombinIIIIII,concentrate,human,assayhuman................................of(2.7.17.)................................2247.3-3952Avianadministration................................................................................849

Avianinfectiousinfectiousbronchitisbronchitisvaccinevaccine(inactivated)......................(live)...................................852851

Anti-TApomorphinelymphocyteAvian

Apparatus(2.1.)..................................................................................hydrochloride.......................................................1407immunoglobulinforhumanuse,animal..1404

15Avianinfectious

Avianinfectiousbursal

infectiousbursaldisease

encephalomyelitisdiseasevaccinevaccine(inactivated)..............854

vaccine(live)............................856(live).....................857ApparentApplicationdissolutionAvianAvianinfectiouslaryngotracheitisvaccine

preparationsofthe(5.1.5.)......................................................................508F(2.9.43.).......................................................320

0concepttosteamsterilisationofaqueousoffinishedlivevirusproductvaccines:(2.6.25.)........................................................testsforextraneous(live).......................859agentsinbatches188Aprotinin..........................................................................................1408Avianparamyxovirus1(Newcastledisease)AprotininArachisoil,concentratedhydrogenated............................................................solution.................................................14111413Avian(inactivated)....................................................................................vaccine

paramyxovirus3vaccine(inactivated).............................860921

ArachisAvianArginine............................................................................................oil,refined..................................................................7.2-3607Aviantuberculinpurified

Arginineaspartate.........................................................................14141415Avianviralproteinderivative............................3161

viraltenosynovitisvaccines:testsvaccineforextraneous(live)........................................agentsinseedlots861

ArginineArgon................................................................................................hydrochloride.................................................................1415Azaperone(2.6.24.)............................................................................................185Aristolochicacidsinherbaldrugs,testfor(2.8.21).................2471416Azathioprine....................................................................................forveterinaryuse......................................................14301431ArnicaAzelastineArnicaflower............................................................................7.3-3859Azithromycin...................................................................................1434hydrochloride..............................................................1433Arsenictincture................................................................................1055(2.4.2.)..................................................................................113ArseniousArticainetrioxideforhomoeopathicB

Artichokehydrochloride.........................................................preparations................1286

leaf...........................................................................7.47.3-4276-3861B19virus(B19V),validationofnucleicacidamplification

ArtichoketechniquesforthequantificationofB19VDNAinplasmaAscorbate,leaf

Ascorbate,calcium.........................................................................1548dryextract............................................................1058

sodium.........................................................................2912Bacampicillinpools:guidelines............................................................................hydrochloride........................................................1439181

AscorbicBacitracin.........................................................................................1440Ascorbylacid...................................................................................1418Bacitracin

Ashinsolublepalmitate.........................................................................1420inhydrochloricacid(2.8.1.).................................239Baclofen...........................................................................................1445zinc................................................................................1443AshBacterial

Ash,leaf.............................................................................................1059Bacterialendotoxins

Ash,sulfatedsulfated(2.4.14.)......................................................................(2.4.14.)(5.8.)..................................................7.1-3346118(5.1.10.)............................................................................................520endotoxins,(2.6.14.)........................................................guidelinesforusingthetestfor171Ash,Baical

Asparaginetotal(2.4.16.)............................................................................Bambuterolskullcaproot................................................................7.1-3355Aspartame........................................................................................monohydrate.............................................................1421118

1421Barbadosaloes...............................................................................1047hydrochloride...........................................................1446

AsparticBarbital.............................................................................................1447Assayacid....................................................................................1423Barium

Assayofof1,8-cineolediphtheriavaccineinessential(adsorbed)oils(2.8.11.)............................240(2.7.6.).........................209Bariumchloridesulfate................................................................................1448dihydrateforhomoeopathicpreparations..1287AssayBasic

Assayofofheparinheparin(2.7.5.).................................................................208incoagulationfactors(2.7.12.)......................220BCGforbutylatedimmunotherapy................................................................methacrylatecopolymer..................................1448746GeneralNotices(1)applytoallmonographsandothertexts4405

欧洲药典7.4索引(现行版)

Indexhttp://www.77cn.com.cn/forum.php?mod=viewthread&tid=21456&fromuid=1023 EUROPEANPHARMACOPOEIA

7.4BCGBitter-fennelBearberryvaccine,leaf..........................................................................freeze-dried.....................................................7.37.1-3833-3356Bitter-fennelfruitherboil......................................................................1073oil.....................................................................1075BeclometasoneBitternessBeclometasonedipropionate,Bitter-orangevalue

Beeforhomoeopathicdipropionatepreparations,monohydrate.............................anhydrous.................................1449

honey.............................12921451Bitter-orange-epicarpepicarp(2.8.15.)................................................................244andandmesocarp..........................................1077mesocarptincture..........................1078Beeswax,Bitter-orangeBitter-orange-flowerflower...............................................................7.3-3865Beeswax,white...............................................................................1453

Belladonnayellow..............................................................................1454leaf........................................................................7.3-3863Blackhorehound....................................................................oil.................................................................7.2-35831194BelladonnaBleomycinBelladonnaleafdryextract,standardised................................1064BloodBelladonna,leafprepared....................................................................1066tincture,standardised.....................................1065plasticisedandsulfate...........................................................................1502bloodpoly(vinylcomponents,chloride)emptyfor(3.2.4.)...............................370sterilecontainersofBenazeprilBloodandbloodcomponents,materialsforcontainersforBendroflumethiazide....................................................................1456hydrochloride.............................................................1454

Benperidol................................................................................7.2-3611Blood(3.1.1.)...............................................................................................329andbloodcomponents,setsforthetransfusionofBenserazideBentonite.........................................................................................1460hydrochloride..........................................................1459Blood(3.2.6.)..............................................................................................Benzalkoniumchloride..........................................................7.1-3385(3.2.3.)..............................................................................................369andbloodcomponents,sterileplasticcontainersfor371BenzalkoniumBlood,BenzathineBlood,anticoagulant

Benzbromarone..............................................................................1465benzylpenicillin........................................................chloridesolution.........................................7.1-33861471containingsterileandpreservativesolutionsfor.............1401

anticoagulantcontainersofsolutionplasticised(3.2.5.)...............................poly(vinylchloride)371BenzethoniumBogbeanBenzocaine......................................................................................1466chloride................................................................1466

Benzoicacid....................................................................................1467BoilingBoldoleaf.........................................................................................pointleaf...................................................................................1080(2.2.12.)........................................................................311081Benzoin,Benzoin,Siam.................................................................................1067Boldo

Benzointincture,Sumatra..........................................................................1068Siam.................................................................1069Borageleafdryextract....................................................................1083

Borax................................................................................................1503(starflower)oil,refined...................................................1503

BenzoinBenzoyltincture,Boric

Benzylalcohol................................................................................1469peroxide,Sumatra...........................................................1069hydrous..........................................................1468Botulinumacid.........................................................................................1504

Botulinumantitoxin........................................................................949toxintypeAforinjection..................................7.3-3898BenzylBenzylpenicillin,benzoate.............................................................................1470Botulinum

Benzylpenicillinpotassium..........................................................1473benzathine.......................................................1471BovinetoxintypeBforinjection..................................

Bovineinfectiousinsulin.................................................................................2239rhinotracheitisvaccine(live)........................9087.2-3615

Benzylpenicillin,Benzylpenicillinprocaine............................................................Bovine

Betacarotene...................................................................................1477sodium...............................................................14741476Bovineleptospirosis

Bovineparainfluenzavaccine

respiratorysyncytialvirusvaccine(inactivated)..................................862

virusvaccine(live)...................................864(live).......................865Betacyclodextrin............................................................................1478Betacyclodextrin,Bovine

Betadex............................................................................................1478poly(hydroxypropyl)ether...................7.3-3953Bovineserum..................................................................................1506

Bovinetuberculinviraldiarrhoeapurifiedvaccineprotein(inactivated)..............................866derivative.........................3161

BetahistineBetahistinedihydrochloride........................................................1479Bromazepam...................................................................................1507Betamethasone...............................................................................mesilate......................................................................14801481BromhexineBromocriptinehydrochloride..........................................................1508mesilate................................................................1509BetamethasoneBetamethasoneacetate................................................................1483Bromperidol.............................................................................Betamethasonedipropionate...............................................sodiumphosphate............................................14867.4-4281Bromperidol7.2-3616

Brompheniraminedecanoate.........................................................maleate...........................................................7.2-36181514BetamethasoneBetaxololvalerate...............................................................1488Brotizolam.......................................................................................

Bezafibrate......................................................................................1490hydrochloride........................................................7.2-3612Brucellosisveterinaryvaccineuse.................................................................................867(live)(BrucellamelitensisRev.1strain)1515forBicalutamide............................................................................Bifonazole.................................................................................7.4-4283Buccal

Bilberryfruit,dried.......................................................................10707.4-4284Buckwheattabletsandsublingualtablets.................................7.4-4259

Budesonide......................................................................................herb.............................................................................10841516BilberryBilberryfruitBufexamac.......................................................................................

Biologicalfruit,dryextract,fresh,refinedandstandardised...1130

assaysfresh........................................................................1070(2.7.)....................................................................201BufferBuflomedilsolutionshydrochloride............................................................(4.1.3.).........................................................7.4-42201518

1519BiologicalBulk

Biological(5.3.)..................................................................................................assaysandtests,statisticalanalysisofresultsof

indicatorsofsterilisation(5.1.2.)..............................504551Bumetanide.....................................................................................1520densityandtappeddensityofpowders(2.9.34.).............305

Bupivacainehydrochloride..........................................................1521BiologicalBiologicalproducts,Buprenorphine...............................................................................1523

(5.2.1.)...............................................................................................527products,generalterminologytextsusedon(5.2.)................................527inmonographsonBuprenorphineBuserelin...................................................................................hydrochloride....................................................15247.2-3620BiologicalBiotin................................................................................................1492tests(2.6.).......................................................................153Buspirone

Biperidenhydrochloride...............................................................1493Busulfan...........................................................................................1529hydrochloride..............................................................1527

Butcher’sbroom.............................................................................1085BiphasicBiphasicinsulininjection.............................................................2243Butylated

Birchleaf..........................................................................................1071isophaneinsulininjection...........................................2244Butylhydroxyanisole......................................................................1531methacrylatecopolymer,basic.................................1448

Butylhydroxytoluene.....................................................................1531Bisacodyl..........................................................................................1495BismuthButylparahydroxybenzoate..................................................7.2-3621

Bismuthsubcarbonate..................................................................1496subgallate........................................................................1497BismuthC

Bismuthsubnitrate,heavy...........................................................1498Cabergoline.....................................................................................1535Bisoprololsubsalicylate...................................................................1498fumarate................................................................7.3-3897Cachets...............................................................................................709BistortCadmium

Bitterfennel....................................................................................1124rhizome..............................................................................1072Caffeine............................................................................................1536sulfatehydrateforhomoeopathicpreparations...12874406Seetheinformationsectionongeneralmonographs(coverpages)

欧洲药典7.4索引(现行版)

EUROPEANPHARMACOPOEIAhttp://www.77cn.com.cn/forum.php?mod=viewthread&tid=21456&fromuid=1023 7.4

IndexCaffeineCalcifediol.................................................................................monohydrate...................................................................15377.3-3903Capsules,Capsules,soft....................................................................................708vaginal..............................................................................739Calcipotriol,Calcipotriolanhydrous................................................................1539Captopril...................................................................................Calcitonin(salmon)........................................................................1544monohydrate............................................................1542Caraway7.4-4289

Carawayfruit...................................................................................1090oil......................................................................................1091Calcitriol....................................................................................Calcium7.3-3904Carbachol.........................................................................................1575

Calcium(2.4.3.).................................................................................acetate,anhydrous..................................................7.3-3905113Carbamazepine...............................................................................1576Carbasalatecalcium.......................................................................1577CalciumCalciumascorbate..........................................................................1548Carbidopa........................................................................................1579Calciumcarbonate.........................................................................1549carboxymethylcellulose................................................1589Carbimazole....................................................................................1580Carbocisteine..................................................................................1581CalciumCalciumchloridedihydrate..........................................................1550Carbomers.......................................................................................1581Calciumchloridedobesilatehexahydrate....................................................1550monohydrate...............................................1551CarbonCarbondioxide...............................................................................1583dioxideingases(2.5.24.).................................................143CalciumCalciumedetate,Carbon

Calciumfolinate.............................................................................1552sodium..............................................................2916

glucoheptonate...............................................................1554Carbonmonoxide(15

Carbonmonoxide....................................................................O)...................................................................965

monoxideingases(2.5.25.).............................................7.2-3625144CalciumCalciumgluconate.........................................................................1555Carboplatin......................................................................................1585

Calciumgluconate,gluconateforanhydrous...................................................1555injection..................................................1556CarboprostCarboxymethylcellulose................................................................1588trometamol................................................................1586CalciumCalciumglycerophosphate...........................................................1557Carboxymethylcellulose

Calciumhydrogenhydrogenphosphate,phosphatedihydrate...................................1559anhydrous................................1558Carboxymethylcellulosecalcium................................................1589

Carboxymethylcellulosesodium.................................................1589sodium,cross-linked.........................1770CalciumCalciumhydroxide.........................................................................1560Carboxymethylcellulose

Calciuminiodideadsorbedtetrahydratevaccinesfor(2.5.14.)........................................141homoeopathicprepara-Carisoprodol....................................................................................1587sodium,low-substituted...................1590

Carmellose.......................................................................................1588

Calciumtions................................................................................................1288Carmellose

Calciumlactate,lactatemonohydrate.....................................................1561anhydrous.........................................................1561Carmellosecalcium........................................................................1589

Carmellosesodium........................................................................1589sodiumandmicrocrystallinecellulose.........7.4-4335CalciumCalciumlactatepentahydrate.....................................................1562Carmellose

Calciumlactatelevofolinatetrihydrate............................................................1562pentahydrate............................................1563Carmustine......................................................................................sodium,low-substituted..........................................1590

Carnaubawax.................................................................................15921591

CalciumCalciumlevulinatedihydrate.......................................................1565Carprofen

Calciumpantothenate...................................................................1566pentetate(sodium)forradiopharmaceuticalCarrageenan....................................................................................1593forveterinaryuse.......................................................1592

Carteololhydrochloride................................................................1594

Calciumpreparations....................................................................................987Carvedilol..................................................................................Calciumphosphate........................................................................1567stearate.............................................................................1567Cascara......................................................................................7.4-4291

Cascaradryextract,standardised..............................................10947.1-3357

CalciumCalendulasulfateCassia

Calfcoronavirusflower............................................................................1086dihydrate............................................................1569

diarrhoeavaccine(inactivated)......................868Castoroil..........................................................................................1095

Castoroil,oil,hydrogenated..............................................................1596polyoxyl........................................................................2398CalfCalicivirosisrotavirusCastor

Calicivirosisvaccinediarrhoea

vaccine(inactivated),vaccine(inactivated)...........................869

(live),feline..................................................896feline.....................................895Castoroil,

Castoroil,polyoxyl

oil,refined..........................................................................1597hydrogenated..............................................2397

virgin.............................................................................1598Camphor,DCamphor,-.....................................................................................1569Catgut,

Candesartanracemic..........................................................................1571cilexetil..............................................................7.3-3906Catgut,sterile..................................................................................1027

CD34/CD45+sterile,cellsindistributorinhaematopoieticforveterinaryproducts,use.....................1037numerationofCanineCanineadenovirus

Canineadenovirusvaccine

distempervaccinevaccine(inactivated)....................................870

(live)....................................................872(live)..................................................871Cefaclor............................................................................................1599(2.7.23.)............................................................................................228

Cefadroxilmonohydrate...............................................................1600CanineCanineleptospirosisCefalexin

Canineparainfluenzavaccine

parvovirosisvaccinevirusvaccine(inactivated)..................................874

(inactivated)...................................(live)...................................875876Cefalotinmonohydrate.................................................................1602

Cefamandolesodium............................................................................1603nafate.......................................................................1605CanineCapeparvovirosisvaccine(live)................................................877Cefapirin

Capillaryaloes........................................................................................1048electrophoresis(2.2.47.)(5.8.)............................7.1-3345Cefatrizinesodium............................................................................1606

Cefazolinsodium............................................................................1608propyleneglycol........................................................1607

CapillaryCapillaryelectrophoresisCefepime

Caprylate,viscometersodium..........................................................................method(2.2.47.).......................................(2.2.9.).............................................7.1-3313

291727Cefixime...........................................................................................dihydrochloridemonohydrate...........................7.2-3626

Cefoperazonesodium...................................................................16121613CaprylicCaprylocaproylacid....................................................................................1571Cefotaxime

Capsicum..........................................................................................1087macrogolglycerides...........................................1572Cefoxitinsodium........................................................................1615

Cefpodoximesodium............................................................................proxetil....................................................................16171618CapsicumCapsicumoleoresin,refinedandquantified............................1089Cefprozil

Capsules.............................................................................................707tincture,standardised................................................1090Cefradine..........................................................................................1620monohydrate..........................................................7.2-3628

Ceftazidimepentahydrate............................................................1622CapsulesCapsulesandandtablets,disintegrationof(2.9.1.)(5.8.).....7.1-3346Ceftazidimepentahydratewithsodiumcarbonatefor

Capsules,gastro-resistant...............................................................708tablets,disintegrationof(2.9.1.)................7.1-3331Ceftriaxoneinjection.........................................................................................1624sodium........................................................................1626Capsules,Capsules,hard..................................................................................708Cefuroxime

Capsules,intrauterine.....................................................................modified-release.............................................................708715Cefuroximeaxetil...........................................................................1627

Celiprololhydrochloride...............................................................1630sodium........................................................................1629

Capsules,Capsules,oromucosal............................................................rectal.................................................................................7337.4-4259Cellcountandviability,nucleated(2.7.29.)...............................233GeneralNotices(1)applytoallmonographsandothertexts4407

欧洲药典7.4索引(现行版)

Indexhttp://www.77cn.com.cn/forum.php?mod=viewthread&tid=21456&fromuid=1023 EUROPEANPHARMACOPOEIA

7.4CellCholera(5.2.4.)..............................................................................................533culturesfortheproductionofveterinaryvaccinesCholeravaccine,vaccine(inactivated,freeze-dried........................................................oral)...............................................749749CellsubstratesfortheproductionofvaccinesforhumanCholesterol......................................................................................1680CholesterolCellular(5.2.3.)..............................................................................................530use

products,microbiologicalcontrolof(2.6.27.)............191Cholesterolforinoilsparenteralrichinomega-3use.............................................acids,total(2.4.32.).........7.3-3910133CelluloseChondroitinCelluloseacetate............................................................................1631Chromatographicsulfatesodium.........................................................

Celluloseacetateacetatebutyrate............................................................1632phthalate...................................................7.3-3908Chromatography,separationgas(2.2.28.)........................................................techniques(2.2.46.).....................16817043Cellulose,Chromatography,CelluloseChromatography,liquid

Cellulose,(microcrystalline)microcrystalline...........................................................1634

powdered......................................................................1638andcarmellosesodium.......7.4-4335Chromatography,paper(2.2.29.)...................................................45

size-exclusion(2.2.26.).....................................................41(2.2.30.).....................................46Centaury..........................................................................................1095Chromatography,Centella............................................................................................1096Chromatography,supercriticalfluid

Cetirizinedihydrochloride....................................................7.3-3909Chromium(51thin-layer(2.2.27.).............................................(2.2.45.).............................7042Cr)edetateinjection...............................................966CetostearylCetostearylalcohol........................................................................1643Chymotrypsin..................................................................................1683Cetostearylalcoholalcohol(type(typeA),B),emulsifying..........................emulsifying..........................7.17.1-3391-3392Ciclopirox.........................................................................................1684Ciclopiroxolamine.........................................................................1686CetostearylCetostearylisononanoate.............................................................1646Ciclosporin......................................................................................1687Cetrimide.........................................................................................1646sulfate,sodium..................................................7.1-3465CilastatinCilazapril..........................................................................................1690sodium...........................................................................1688CetylCetylalcohol...................................................................................1647Cimetidine........................................................................................Cetylpyridiniumpalmitate................................................................................1648chloride..............................................................1648CimetidineCinchocainehydrochloride.............................................................16931691

hydrochloride..........................................................1694CeylonCeyloncinnamonbarkoil.....................................................7.1Cinchona

CFCassaycinnamonforhumanleafoil..............................................................-3359

haematopoieticprogenitorcells1102Cinchonabark................................................................................1098

Cineole..............................................................................................1695liquidextract,standardised.......................................1100

Chamomile(2.7.28.)............................................................................................232Cineole

Characterisationflower,ofRoman...........................................................1098crystallineandpartiallycrystallinesolidsCinnamon.................................................................................inessentialoils,1,8-,assayof(2.8.11.).........................240

Cinnamonbarkoil,Ceylon...................................................7.17.1-3359-3359

CharacterisationbyX-raypowderdiffraction(XRPD)(2.9.33.)..........................301Cinnamon

(2.9.44.)...................................................................................ofpreparationsfornebulisation7.3-3803Cinnamonleafoil,Ceylon............................................................1102

Cinnarizine...............................................................................tincture.........................................................................7.2-36301103

CharactersCharcoal,sectioninmonographs(5.11.)..................................637Ciprofibrate.....................................................................................1697Chenodeoxycholicactivated........................................................................1649acid................................................................1650Ciprofloxacin...................................................................................1698Ciprofloxacinhydrochloride.................................................7.4-4292ChewingChewinggums,Circular

(2.9.25.)...................................................................................gums,medicated.............................................................709medicated,dissolutiontestfor7.4-4097Cisplatin...........................................................................................dichroism(2.2.41.).............................................................65

Citalopramhydrobromide.....................................................7.1-33961701

ChickenChickenanaemiavaccineCitalopram

andqualityflockscontrolfreefromofvaccinesspecified(live),infectious.................................

(5.2.2.).....................................527pathogensfortheproduction910Citrichydrochloride............................................................1704

Citricacid,acidmonohydrate...............................................................1706anhydrous...................................................................1705

ChitosanChlamydiosishydrochloride................................................................Citronella

Chloralhydrate...............................................................................1652vaccine(inactivated),feline.................................8971651Cladribine........................................................................................1707oil....................................................................................1103

Clarithromycin................................................................................1708Chlorambucil............................................................................Chloramine......................................................................................7.1-3393Clarity

Chloramphenicol............................................................................16533118Claryanddegreeofopalescenceof

Classicalsageliquids(2.2.1.)...................21

swine-feveroil...................................................................................vaccine(live,preparedincellcultures)..9401104

ChloramphenicolChloramphenicolpalmitate.........................................................1654Clazuril

Chlorcyclizinehydrochloride......................................................1656sodiumsuccinate...........................................1655Cleboprideforveterinaryuse...........................................................1710

Clemastinemalate..........................................................................fumarate.....................................................................17121713Chlordiazepoxide...........................................................................1657ChlordiazepoxideClenbuterol

Chlorhexidinediacetate................................................................1659hydrochloride................................................1658Clindamycinhydrochloride...........................................................1715

Clindamycinhydrochloride..........................................................phosphate................................................................17161717ChlorhexidineChlorhexidinedigluconatesolution..........................................1660Clioquinol........................................................................................

Chlorides(2.4.4.)..............................................................................dihydrochloride...................................................1662113Clobazam.........................................................................................1718

Clobetasolpropionate...................................................................17201719

Chlorobutanol,Chlorobutanolanhydrous...........................................................1663Clobetasone

Chlorocresol....................................................................................1664hemihydrate........................................................1663ClodronateClofazimine......................................................................................1724disodiumbutyrate....................................................................1722tetrahydrate.............................................1723ChloroquineChloroquinephosphate................................................................1665Clofibrate.........................................................................................1725Chlorothiazide................................................................................1666sulfate.......................................................................1665ClomifeneClomipraminecitrate............................................................................1726hydrochloride.......................................................1727ChlorphenamineChlorpromazineClonazepam.....................................................................................1729Chlorpropamide..............................................................................1669hydrochloride...................................................1668maleate.............................................................1667ClonidineClopamide........................................................................................hydrochloride...............................................................17301731ChlorprothixeneChlortalidone..................................................................................1671hydrochloride..................................................1670Clopidogrel

Chlortetracyclinehydrochloride.................................................1673Clorazepate,hydrogensulfate...............................................7.1-3397

Closantelsodiumdipotassium.............................................................1869dihydrateforveterinaryuse.......................1732Cholecalciferol................................................................................CholecalciferolClostridium

Cholecalciferolconcentrateconcentrate(oily(powderform).....................................16751674

form)..............................1677Clostridiumbotulinum

Clostridiumchauvoeinovyialphavaccinevaccine

antitoxinforforveterinaryveterinaryuse...................878

forveterinaryuse......................879use..............957CholecalciferolCholeravaccine................................................................................concentrate(water-dispersibleform).............1678748ClostridiumClostridiumnovyiperfringens(typeB)betavaccineantitoxinforveterinaryforveterinaryuse.............879use....958

4408Seetheinformationsectionongeneralmonographs(coverpages)

欧洲药典7.4索引(现行版)

EUROPEANPHARMACOPOEIAhttp://www.77cn.com.cn/forum.php?mod=viewthread&tid=21456&fromuid=1023 7.4

IndexClostridiumConeflower...........................................................................................................959perfringensepsilonantitoxinforveterinaryuseConjugatedroot,estrogens...................................................................1958purple...............................................................1219ClostridiumConsistencyContainersbypenetrometry,Clostridiumperfringensvaccineforveterinaryuse.................881

Closuresandsepticumcontainersvaccineforparenteralforveterinarypreparationsuse......................883andContainers(3.2.)...............................................................................363measurementof(2.9.9.)..........267

andclosuresforparenteralpreparationsand

ClosuresophthalmicContainersophthalmic

(3.2.2.)..............................................................................................368andpreparations,containersforpolypropylenepharmaceuticalforuse,(3.1.6.)..............342plastic(3.2.2.)..............................................................................................368andpreparations,closuresforpolypropylenepharmaceuticalforuse,(3.1.6.)..............342plasticClosuresContainersClosuresandtubing,siliconeelastomerfor(3.1.9.).................347

powdersforandcontainersforfreeze-driedforaqueouspowders,parenteralrubberpreparations,(3.2.9.).........374forContainerspreparations,andtubingfortotalparenteralnutrition

forpoly(ethyleneaqueoussolutions-vinylforacetate)infusion,forplastic(3.1.7.).........345

Clotrimazole....................................................................................1734Clove.................................................................................................Containers(3.2.2.1.)...........................................................................................368Cloveoil...........................................................................................11051106materialsbasedforaqueousonplasticisedsolutionspoly(vinylforintravenouschloride)infusion,forCloxacillinClozapine.........................................................................................1737sodium..........................................................................1735Containers(3.1.14.)............................................................................................355CoagulationfactorII,assayof(2.7.18.).......................................224materialsbasedfordryondosagenon-plasticisedformsforpoly(vinyloraladministration,chloride)forCoagulationCoagulationfactorIX,human.....................................................Containers(3.1.11.).............................................................................................350Coagulationfactorfactors,IX,activatedhuman,(2.6.22.).......................................assayof(2.7.11.).......................2172219185basedonplasticisedforhumanpoly(vinylbloodandchloride)bloodcomponents,for(3.1.1.1.)..........329materialsCoagulationContainersforhumanbloodandbloodcomponents,Coagulationfactors,

Coagulationfactorassayofheparin(2.7.12.).........................220

factorVII,VII,human...................................................human,assayof(2.7.10.).....................2169219Containersfor(3.1.1.)........................................................................................329materials

forhumanbloodandbloodcomponents,plastic,CoagulationCoagulationfactorContainerssterile(3.2.3.)..................................................................................369

CoagulationfactorVIII,

factorVIII,human..................................................

VIII(rDNA),human,human...................................assayof(2.7.4.)......................2072170

2171basedonnon-plasticisedfornon-injectablepoly(vinylaqueouschloride)solutions,formaterials(3.1.10.)...349CoagulationContainersforparenteralpreparationsandforophthalmicCoagulationfactorX,assay

CoagulationfactorfactorXI,of(2.7.19.).......................................225

XI,human.....................................................human,assayof(2.7.22.)......................2272173Containerspreparations,forpolyethyleneparenteralpreparationswithadditivesandforfor(3.1.5.)...........338ophthalmicCoatedCoatedgranules...............................................................................Containerspreparations,

Cocainetablets...................................................................................737714

hydrochloride..................................................................1738Containersforpolyethylene

forpharmaceuticalwithoutadditivesfor(3.1.4.).....337

preparationsnotuse,forglassparenteral(3.2.1.).....................363use,polyethyleneCoccidiosisCoconutContainersterephthalate

Cocoylcaprylocaprate...................................................................oil,vaccinerefined.......................................................................1739(live)forchickens........................................884

1740andbloodofcomponents,plasticisedfor(3.1.15).............................................................357poly(vinylemptysterilechloride)(3.2.4.).........................370forhumanblood

Codeine............................................................................................Containersofplasticisedpoly(vinylchloride)forCodeine1740

Codeinehydrochloridephosphatehemihydrate................................................dihydrate...............................................17421743Contamination,containinganticoagulantmicrobial:solution,humanblood

microbialsterileenumeration(3.2.5.).................tests371

CodeineCodergocrinephosphatesesquihydrate.............................................1745Contamination,(2.6.12.)............................................................................................163Cod-liveroil,farmed......................................................................mesilate..................................................................17471748(5.8.).........................................................................................microbial:microbialenumerationtests7.1(2.6.12.)-3346Cod-liverContamination,microbial:testforspecifiedmicro-organismsCod-liveroil(type

Cola...................................................................................................oil(typeA)......................................................................1752B)......................................................................17561107Contamination,(2.6.13.)............................................................................................167Colchicine.................................................................................microbial:testforspecifiedmicro-organismsCold-water7.2-3631

Colestyramine.................................................................................vibriosisvaccine(inactivated)forsalmonids.........9431761Content(2.6.13.)

ColibacillosisControlofuniformity(5.8.)........................................................................7.1-3346

impuritiesofinsingle-dosesubstancespreparationsforpharmaceutical(2.9.6.)..........266use

Colibacillosisvaccine(inactivated),neonatal

Colistimethatevaccinesodium..................................................................(inactivated),neonatalpiglet.................ruminant..........920918

1762Control(5.10.).......................................................................................

Colistin(5.1.6.)...............................................................................................508ofmicrobiologicalquality,alternativemethods7.4for-4247Colloidalsulfate................................................................................Copolymer,

Colloidalanhydroushydratedsilica...............................................................2902silica............................................................29011763Copolymer,basicbutylatedmethacrylate................................1448ColloidalCopolymer,grafted,methacrylicmacrogolacid-poly(vinylethylacrylatealcohol)..................2401(1:1).................2459Colloidalsilica,hydrophobic.......................................................2903Copolymer,methacrylicacid-ethylacrylate

Colony-formingsilver,forcellexternalassayforuse.................................................2904humanhaematopoieticprogenitorCopolymer,30percent.............................................................................(1:1)dispersion

methacrylicacid-methylmethacrylate7.2-3679

Colophony.......................................................................................cells(2.7.28.)...................................................................................232

Colorationofliquids(2.2.2.)............................................................110722Copolymer,(1:1)http://www.77cn.com.cnmon(1:2)..........................................................................................methacrylicacid-methylmethacrylate7.2-3680

7.2-3681

ComparativestingingCopolymer

Complexometrictablenettle

titrationsofporosityforhomoeopathic

(2.5.11.)..............................................ofsintered-glasspreparations.....1288filters(2.1.2.)..14015Copolymer(type

CompositionCopovidone...............................................................................(typeA),B),ammonioammoniomethacrylate...........................1381methacrylate...........................13827.2-3633CompositionoffattyacidsbyCopper

(2.4.29.)............................................................................................offattyacidsingasoilschromatographyrichinomega-3acids(2.4.22.)..119

130CompressedCoppertions................................................................................................1289acetatemonohydrateforhomoeopathicprepara-

forhomoeopathicpreparations....................................1289

Concentratedlozenges.............................................................Copper

Concentratesforsolutions7.4-4259

injectionsforhaemodialysis...............................2136orinfusions.....................................725Coppersulfate,

ConcentratesCoriander.........................................................................................sulfatepentahydrate.......................................................anhydrous...........................................................176617661108Conductivityforintrauterinesolutions......................................715Coriander

Coneflowerherb,(2.2.38.)........................................................................purple..............................................................121859Cortisoneoil...................................................................................ConeflowerCotton,absorbent..........................................................................acetate...........................................................................110817671768Coneflowerroot,root,narrow-leaved..................................................pale....................................................................12081193CottonseedCouchgrassoil,rhizome.............................................................hydrogenated....................................................7.1-33601769GeneralNotices(1)applytoallmonographsandothertexts4409

欧洲药典7.4索引(现行版)

Indexhttp://www.77cn.com.cn/forum.php?mod=viewthread&tid=21456&fromuid=1023 EUROPEANPHARMACOPOEIA

7.4Creams................................................................................................735Cresol,crude...................................................................................1770DexamethasoneDexamethasoneacetate................................................................1809isonicotinate.....................................................1811Cromoglicate,Croscarmellosesodium............................................................Dexamethasone

Crospovidone...........................................................................sodium.................................................................17707.4-4368

7.4-4294Dexchlorpheniraminesodium

Dexpanthenol..................................................................................maleate....................................................phosphate...........................................181218141815Crotamiton......................................................................................1773CrystallineDextran

byX-raypowderandpartiallydiffractioncrystalline(XRPD)solids,of(2.9.33.).....................characterisation301Dextran1

Dextran40for

60forinjection..................................................................1816

forinjection...............................................................injection...............................................................18171818CrystallinityCutaneous(5.16.).................................................................7.4-4253Dextran

Cutaneousapplication,application,liquidpowderspreparationsfor............................................726for.........................717Dextranomer...................................................................................70forinjection...............................................................1819

Dextrans,molecularmassdistributionin(2.2.39.)....................181960CutaneousCutaneousapplication,Dextrin..............................................................................................1820

for.............................................................................................application,semi-solidveterinarypreparationsliquidpreparationsfor.................734

7.4-4259DextromethorphanDextromoramidetartrate.............................................................1822hydrobromide.............................................1821

CutaneousCutaneousfoams..............................................................................Dextropropoxyphene

Cyanocobalamin.............................................................................patches..........................................................................734717Diazepam.........................................................................................1824hydrochloride..........................................1823

571774Diazoxide.........................................................................................1825CyanocobalaminCyanocobalamin(Dibrompropamidine

Cyanocobalamin(57Co)

(58Co)capsules..................................................967Co)solution...................................................968capsules..................................................968DibutylDichloromethane............................................................................2474phthalate...........................................................................1827diisetionate................................................1826

CyanocobalaminCyclamate,(58Diclazuril

Cyclizinehydrochloride................................................................1775sodium.........................................................................2924Co)solution...................................................969Diclofenacforveterinaryuse........................................................1828

Diclofenacpotassium....................................................................1829sodium.........................................................................1830CyclopentolateCyclophosphamide.........................................................................1777hydrochloride.....................................................1776Dicloxacillin

Cyproheptadinehydrochloride...................................................1778Dicycloverinesodium......................................................................1831

Didanosine.......................................................................................1833hydrochloride........................................................1833

CyproteroneCysteineacetate...............................................................7.4Dienestrol........................................................................................1835Cystine..............................................................................................1782hydrochloridemonohydrate.......................................-42951781DiethylcarbamazineDiethyleneglycolandcitrate..........................................................1836ethyleneglycolinethoxylatedsubstancesCytarabine.......................................................................................1783Diethylene(2.4.30.)............................................................................................132DDiethyleneglycolglycolmonoethylpalmitostearate..............................................1839ether............................................1837Dacarbazine.....................................................................................1787Diethyl

Dalteparinsodium.........................................................................1788Diethylstilbestrol............................................................................1839phthalate...........................................................................1835DanaparoidDiffraction,laserlight,particlesizeanalysisby(2.9.31.).......295DandelionDifloxacin

Dandelionherbsodium.......................................................................1789

root................................................................................withroot.............................................................11101111Diflunisal..........................................................................................1840hydrochloridetrihydrateforveterinaryuse..7.4-4301

Dapsone...........................................................................................1792Digitalisleaf.............................................................................7.2-3584Daunorubicinhydrochloride.......................................................1792Digitoxin...........................................................................................D-Camphor.......................................................................................1569Digoxin.............................................................................................18421841DecylDihydralazinesulfate,hydrated..................................................1844Deferoxamineoleate.....................................................................................1794Dihydrocodeine

Degreeofcolorationmesilate..................................................................1794ofliquids(2.2.2.)..........................................22Dihydroergocristinehydrogen

DembrexinehydrochlorideDihydroergotaminemesilate.......................................................1849mesilate......................................................1846tartrate.............................................1845

Dihydroergotamine

Demeclocyclinenaryuse.........................................................................................1795monohydrateforveteri-

hydrochloride....................................................1796Dihydrostreptomycintartrate........................................................1850

DensityDihydrotachysterol........................................................................1853sulfateforveterinaryuse......................1851Densityofpowders,bulkdensityandtapped(2.9.34.)...........305Diltiazem

Densityofofsolidssolids,(2.2.42.).................................................................gaspycnometric(2.9.23.)...............................28866Dimenhydrinate..............................................................................1856hydrochloride........................................................7.4-4302Density,Dimercaprol.....................................................................................1858Dentalrelative(2.2.5.)....................................................................25Dimethylacetamide........................................................................1859Depressortypesubstancessilica............................................................................2903(2.6.11.)......................................................162Dimethylaniline,

DeptropineDimethylsulfoxide.........................................................................1858N,N-(2.4.26.)......................................................128Dequaliniumcitrate..........................................................................1797Dimeticone...............................................................................Desacyl-4′-monophosphorylchloride....................................................................1798lipidA,3-O-...........................7.2-3639Dimetindene7.2-3640Desflurane.......................................................................................1800Dinoprostone..................................................................................1863maleate....................................................................1860DesipramineDinoprost

Deslanoside.....................................................................................1802hydrochloride.........................................................1801Diosmin............................................................................................1864trometamol...................................................................1862Desmopressin..................................................................................1803Dioxanandethyleneoxide(2.4.25.)............................................127Desogestrel......................................................................................1804Dip

Desoxycortoneacetate..................................................................1805Diphenhydramineconcentrates.....................................................................7.4DetectorDiphenoxylatehydrochloride...............................................hydrochloride................................................1866-4260

7.4-4304

Determinationtubes,Diphtheriaandtetanustoxinsandtoxoids,flocculationvalueDeterminationofgas

ofaflatoxin(2.1.6.)...............................................................17

essentialBoils1ininherbalherbaldrugsdrugs(2.8.18.)..........244(2.8.12.)........241DeterminationDiphtheria(Lf)of,(Ramonandtetanusassay)(2.7.27.)...................................................vaccine(adsorbed)...............................231751

DeterminationofDiphtheriaandtetanusvaccine

Determinationofnitrogen

ofprimarybysulfuricaciddigestion(2.5.9.)..139

tanninsinaromaticherbalamino-nitrogendrugs(2.8.14.)..................243(2.5.8.)..139

DeterminationofwaterbydistillationDiphtheriacontent)............................................................................................752(adsorbed,reducedantigen(s)

antitoxin........................................................................949

DetomidineDiphtheria,tetanusandhepatitisB(rDNA)

Devil’sclawhydrochloridedryextract.................................................................forveterinary(2.2.13.)...........................31use.........................18061112Devil’sDiphtheria,(adsorbed)........................................................................................753vaccine

tetanusandpertussis(acellular,component)

Dexamethasone..............................................................................1807clawroot.............................................................................1113vaccine(adsorbed).........................................................................7544410Seetheinformationsectionongeneralmonographs(coverpages)

欧洲药典7.4索引(现行版)

EUROPEANPHARMACOPOEIAhttp://www.77cn.com.cn/forum.php?mod=viewthread&tid=21456&fromuid=1023 7.4

IndexDiphtheria,..................................................................................................tetanusandpertussis(wholecell)vaccine(adsorbed)7.2-3569DorzolamideDosageformshydrochloride.........................................................1890(glossary).................................................................707Diphtheria,Dosage

Diphtheria,(adsorbed,tetanus

tetanus,reducedand

pertussisantigen(s)poliomyelitis

(acellular,content)....................................756(inactivated)vaccine

component)andDosulepinunits,uniformityof(2.9.40.)..................................7.4-4101

Doxapramhydrochloride..............................................................1892hydrochloride..............................................................1893

Diphtheria,haemophilustypebconjugateDoxazosin

hepatitisBtetanus,(rDNA)vaccinepertussis(adsorbed).....................................(acellular,vaccine(adsorbed)................758component)and760Doxepinmesilate........................................................................1894

Doxorubicinhydrochloride.................................................................1895hydrochloride..........................................................1897Diphtheria,tetanus,pertussis(acellular,component)Doxycycline

Diphtheria,poliomyelitistetanus,(inactivated)pertussisvaccine(acellular,(adsorbed)........................and

component)and762Doxycyclinehyclate................................................................

Doxylaminemonohydrate............................................................18997.4-4305

hydrogensuccinate.................................................1901poliomyelitisDroperidol.................................................................................

Diphtheria,antigen(s)content)........................................................................(inactivated)vaccine(adsorbed,reduced

tetanus,pertussis(acellular,component),hepatitis763BDroppersDroppoint(2.1.1.).................................................................................7.2-3644

(2.2.17.)............................................................................1532(rDNA),Drops

Diphtheria,conjugatepoliomyelitisvaccinetetanus,(adsorbed)......................................................(inactivated)andhaemophilustypeb

pertussis(acellular,component),765Drops,(nasal)andsprays(liquid

Drospirenone..................................................................................1903oral.........................................................................................nasal).......................................720719

poliomyelitis(inactivated)andhaemophilusDry

Diphtheria,vaccine(adsorbed).........................................................................typebconjugate

tetanus,pertussis(wholecell)andpoliomyelitis768Dryextracts.......................................................................................676

Duckresidueplagueofvaccineextracts(live).............................................................888(2.8.16.)....................................................244

Diphtheria,(inactivated)vaccine(adsorbed)........................................7.2-3570Duck

(inactivated)tetanus,andhaemophiluspertussis(wholetypebcell),conjugatepoliomyelitisvaccineDwarfviral

Dydrogesterone..............................................................................1905pinehepatitisoil.................................................................................typeIvaccine(live).....................................8891116

Diphtheria(adsorbed)...............................................................................

Diphtheriavaccinevaccine(adsorbed)......................................................7.2-3572

(adsorbed),assayof(2.7.6.)........................209774E

DiphtheriaEar

Dipivefrinevaccine(adsorbed,reducedantigencontent).......776Eardropsandearsprays.......................................................7.1-3351Dipotassiumhydrochloride............................................................1867clorazepate..............................................................1869Earpowders.............................................................................preparations......................................................................7.17.1-3352-3351DipotassiumEar

Diprophylline...........................................................................phosphate................................................................1870Earpreparations,

Dipyridamole...................................................................................18717.3-3915Earspraystampons.............................................................................andearsemi-solid.................................................drops.......................................................7.17.1-3351

7.1-3351-3352

Dirithromycin..................................................................................1872Ear

DisintegrationEbastine...........................................................................................1909washes................................................................................7.1-3352Disintegrationofofsuppositoriestabletsandcapsulesandpessaries(2.9.1.)(2.9.2.).............255(5.8.)......7.1-3346Econazole........................................................................................1910DisintegrationEconazole

Disodiumoftabletsandcapsules(2.9.1.).................7.1-3331Edetate(chromiumnitrate...........................................................................(511911

Disodiumclodronateedetate...........................................................................tetrahydrate.............................................17231874Edetate,disodium..........................................................................Cr))injection............................................9661874DisodiumEdetate,

Disodiumetidronate......................................................................1979Edeticsodiumcalcium..............................................................2916Disodiumpamidronatephosphate,anhydrous.........................................pentahydrate........................................26607.2-3641Edrophoniumacid.......................................................................................chloride..................................................................19121913DisodiumEffervescent

Disodiumphosphatedihydrate............................................Effervescentgranules......................................................................Disopyramide..................................................................................1876phosphatedodecahydrate..................................7.27.2-3641-3642Effervescentpowders......................................................................727714

tablets.........................................................................737

DisopyramideEfficacy

Dispersiblephosphate..............................................................1877Efficacyof

Dissolution,tablets...........................................................................737apparent(2.9.43.)......................................................320(5.2.7.)...............................................................................................538ofantimicrobialveterinaryvaccinespreservationandimmunosera,(5.1.3.)...........................505evaluationofDissolution,Egg

Dissolutionintrinsic(2.9.29.).......................................................294Elderdropsyndrome′76vaccine(inactivated)............................891Dissolutiontesttestforforlipophilicsoliddosagesolidformsdosage(2.9.3.)................forms(2.9.42.)....7.3-3797319Electrophoresisflower.....................................................................................(2.2.31.)...................................................................111746DissolutionElectrophoresis

DissolutiontestElectrophoresis,(2.2.31.)

Distempervaccinetesting,fortransdermal

(live),recommendationspatches

canine...................................................872on(2.9.4.)......................263(5.17.1.)..................665Electrophoresis,capillary(5.8.).............................................

capillary(2.2.47.)7.1-3345

(2.2.47.)......................................(5.8.)...........................7.17.1-3345-3313

DistemperEleutherococcus.............................................................................Distillationvaccine(live)formustelids........................................887Emedastine1118Distributionrangeestimation(2.2.11.)................................................................byanalyticalsieving,particle-size30Emetinehydrochloridedifumarate.................................................................heptahydrate........................................19131914Emetine

Distribution(2.9.38.)............................................................................................Emptyhydrochloride

(2.9.38.)(5.8.)........................................................................estimationbyanalyticalsieving,particle-size313

7.1-3347humansterilebloodcontainerspentahydrate........................................

andbloodofcomponentsplasticised(3.2.4.)..........................370poly(vinylchloride)for1915

Disulfiram........................................................................................1878Emulsifying

Dithranol..........................................................................................1879Emulsifyingcetostearylalcohol

DL-Methionine.................................................................................2466Emulsions,solutionscetostearylandalcohol(type

suspensions,(typeA)...........................B)...........................7.1-3391

oral..............................7.1-3392718

DLEnalaprilat

Dobesilate-α-Tocopherylhydrogensuccinate.........................................3110Enalaprildihydrate....................................................................Dobutaminemonohydrate,hydrochloride..........................................................1880calcium..............................................1551Encephalitismaleate...........................................................................1918

vaccine(inactivated),tick-borne...........................8341916

DocetaxelEndotoxins,

DocusateEndotoxins,bacterial

Dodecylgallate...............................................................................1884sodium............................................................................1883trihydrate......................................................................1881

(5.1.10.)............................................................................................520bacterial,(2.6.14.).......................................................guidelinesforusingthetestfor171

DogEnilconazole

Domperidone...........................................................................rose...........................................................................................1115Enoxaparin

Domperidonemaleate...................................................................18867.2-3643Enoxolone........................................................................................sodium........................................................................1920forveterinaryuse..................................................1919

1921

DopamineEnrofloxacin

Dopexaminehydrochloride..............................................................1887dihydrochloride......................................................1889Entacapone...............................................................................forveterinaryuse..................................................19227.3-3919GeneralNotices(1)applytoallmonographsandothertexts4411

欧洲药典7.4索引(现行版)

Indexhttp://www.77cn.com.cn/forum.php?mod=viewthread&tid=21456&fromuid=1023 EUROPEANPHARMACOPOEIA

7.4EnzooticEthylEphedraherb..................................................................................1120pneumoniavaccine(inactivated),porcine.................927Etidronateparahydroxybenzoatedisodium......................................................................1979sodium...................................7.3-4005Ephedrine,EtilefrineEphedrineanhydrous...................................................................1925Etodolac...........................................................................................hydrochloride...............................................................1979Ephedrinehemihydrate................................................................1926hydrochloride.............................................................1927Etofenamate....................................................................................19821981EphedrineEtofylline..........................................................................................1984Epinastinehydrochloride,racemic.............................................1928Etomidate........................................................................................1985Epinephrine.....................................................................................1329hydrochloride.............................................................1928Etoposide..................................................................................7.1-3408EpinephrineEucalyptusEpirubicintartrate.....................................................................1330Eucalyptusleaf...............................................................................1122Equineherpesvirushydrochloride.............................................................1929vaccine(inactivated)...................................892Eugenol............................................................................................1990oil.................................................................................1123EquineEuropeanEquisetuminfluenzavaccineEuropeangoldenrod.....................................................................1142Ergocalciferol..................................................................................stem.......................................................................(inactivated).......................................8937.4-42671931Evaluationviperofefficacyvenomofantiserum................................................953veterinaryvaccinesandimmunoseraErgometrineErgotaminemaleate.....................................................................1933Evaluation(5.2.7.)...............................................................................................538

immunoseraofsafety(5.2.9.)......................................................................547ofeachbatchofveterinaryvaccinesandErysipelasvaccinetartrate.......................................................................1934(inactivated),swine.......................................939Erythritol.........................................................................................1935EvaluationofsafetyofveterinaryvaccinesandimmunoseraErythromycin...........................................................................Erythromycinestolate...................................................................19387.3-3920Evening(5.2.6.)..............................................................................................536primroseoil,refined......................................................1991ErythromycinExtractableErythromycinethylsuccinate................................................

Erythromycinlactobionate..........................................................19427.3-3923

stearate...........................................................7.3-3925Extractable(2.9.17.).............................................................................................273volumeofparenteralpreparations,testfor

volumeofparenteralpreparations,testfor(2.9.17.)ErythropoietinEserineconcentratedsolution.......................................1946Extracts..............................................................................................(5.8.).........................................................................................7.1-3346

Eserinesalicylate...........................................................................2726sulfate................................................................................2727Extracts,dry......................................................................................674676EsketamineExtracts,Esomeprazolehydrochloride...........................................................1950Extracts,dryresidueof(2.8.16.)...................................................244Essentialoils.....................................................................................673magnesiumtrihydrate........................................1951Extracts,liquid..................................................................................675Essentiallossondryingof(2.8.17.)..............................................244Essentialoils,Extracts,

(2.8.7.)...............................................................................................239oils,assayfattyoilsof1,8-cineoleandresinifiedin(2.8.11.)...........................240essentialoilsinExtracts,soft.....................................................................................EssentialExtraneouswateragentsforpreparation676

inviralvaccinesof.......................................forhumanuse,tests7.4for-4391

Essentialoils,

Essentialoilsoils,inforeign

odourherbalesters

anddrugs,in(2.8.6.).......................................239

tastedetermination(2.8.8.)........................................240of(2.8.12.).......241Extraneous(2.6.16.)............................................................................................

Essentiallivevirusvaccinesagents:tests(2.6.25.)..........................................................inbatchesoffinishedproductofavian176

188

Essentialoils,Extraneousagents:testsinseedlotsof

Essentialoils,residueonevaporation(2.8.9.)...........................240

oils,solubilitywaterin(2.8.5.)......................................................239inalcohol(2.8.10.)...............................240

EsterEye(2.6.24.)............................................................................................avianviralvaccines

drops...........................................................................................185711

Estradiolvalue(2.5.2.)...........................................................................137Eye

Estradiolbenzoate.........................................................................1953hemihydrate...................................................................1954Eyelotions.........................................................................................EstradiolEyepreparations..............................................................................711

preparations,semi-solid..........................................................710712

Estriol........................................................................................valerate...........................................................................1955

Estrogens,conjugated..................................................................19587.2-3649F

EtacrynicF0concepttosteamsterilisationofaqueouspreparations,Etamsylate................................................................................acid.................................................................................1960

Ethacridinelactatemonohydrate...............................................19627.1-3407FactorapplicationII,humanof(5.1.5.)....................................................................508coagulation,assayof(2.7.18.).......................224EthambutolFactor

EthanolFactorIX,

Ethanol,(96hydrochloride...........................................................1963

anhydrous.......................................................................1966percent)....................................................................1964FactorIX,human

VII,humancoagulation....................................................

humancoagulation,2172

coagulation...................................................assayof(2.7.11.)......................2169219

EthanolFactor

Ether.................................................................................................1968contentandalcoholimetrictables(2.9.10.)................268FactorVII,humancoagulation,assayof(2.7.10.)....................219Ether,anaesthetic..........................................................................1968FactorVIII,VIII,humanhumancoagulation.................................................coagulation,assayof(2.7.4.).....................2072170Ethinylestradiol.......................................................................Factor

Ethionamide....................................................................................19707.4-4311FactorVIII

Ethosuximide..................................................................................1971FactorX,(rDNA),humancoagulation...................................2171

XI,humanhumancoagulation,coagulation....................................................assayof(2.7.19.).......................2252173

Ethoxylatedsubstances,ethyleneglycolanddiethyleneFactorFallingXI,humancoagulation,assayof(2.7.22.)......................227Ethylin(2.4.30.).......................................................................................glycol

acetate...................................................................................1972132Famotidine.......................................................................................1995ballviscometermethod(2.2.49.)......................................83EthylFat,

Ethylacrylate-methacrylicacidcopolymer(1:1)..................2459Fattyhard...........................................................................................214630peracrylatecent.............................................................................-methacrylicacidcopolymer(1:1)dispersion7.2-3679Fattyacids,acidsincompositionoilsrichinbyomega-3gaschromatographyacids,composition(2.4.22.)....of119Ethylcellulose.................................................................................1975Ethylenediamine............................................................................1977Fatty(2.4.29.)............................................................................................EthyleneglycolanddiethyleneglycolinethoxylatedsubstancesFattyoils,oilsandalkalineherbalimpuritiesdrugs,heavyin(2.4.19.)...................................130

metalsin(2.4.27.).............119129Fatty

Ethylene(2.4.30.)............................................................................................132

Ethyleneglycolglycolmonopalmitostearate.......................................1976monostearate.....................................................1976Fatty(2.8.7.)...............................................................................................239oilsandresinifiedessentialoilsinessentialoils

oils,foreignoilsin,bythin-layerchromatography

EthyleneEthylhexanoicoxideanddioxan(2.4.25.)............................................127Fatty(2.4.21.)............................................................................................Ethylmorphineacid,hydrochloride.....................................................19782-(2.4.28.).....................................................130(2.3.2.)..............................................................................................oils,identificationbythin-layerchromatography119

110

EthylFatty

Ethyloleate.....................................................................................1973parahydroxybenzoate.........................................................1973Fattyoils,oils,sterolsvegetable.........................................................................703in(2.4.23.)................................................7.2-35354412Seetheinformationsectionongeneralmonographs(coverpages)

欧洲药典7.4索引(现行版)

EUROPEANPHARMACOPOEIAhttp://www.77cn.com.cn/forum.php?mod=viewthread&tid=21456&fromuid=1023 7.4

IndexFcFebantelfunctionforofveterinaryimmunoglobulin,use..........................................................1996testfor(2.7.9.)........................217FluoxetineFlupentixolhydrochloride.............................................................2048dihydrochloride........................................................2049Felbinac............................................................................................1997FelineFluphenazine

Felinecalicivirosiscalicivirosisvaccinevaccine(inactivated).....................................895(live)...................................................896Fluphenazinedecanoate..............................................................2051

Fluphenazinedihydrochloride.............................................enantate.................................................................20547.2-3654

FelineFelinechlamydiosisvaccine(inactivated)...................................897Flurazepam

(inactivated)....................................................................................898infectiousenteritis(felinepanleucopenia)vaccineFlurbiprofen....................................................................................2056monohydrochloride................................................2055

Fluspirilene.....................................................................................2057Felineinfectiousenteritis(felinepanleucopenia)vaccineFlutamide.........................................................................................2058

Feline(live)..................................................................................................899leukaemiavaccine(inactivated)........................................900FluticasoneFlutrimazole....................................................................................2061propionate..........................................................7.3-3931FelineFelinepanleucopeniavaccine(inactivated)................................898Fluvastatin

Felinepanleucopeniaviralrhinotracheitisvaccinevaccine(live).............................................899(inactivated)......................901Fluvoxaminesodium........................................................................2062

Foams,cutaneous............................................................................maleate.............................................................7.2-3656717FelineFelodipine........................................................................................1998viralrhinotracheitisvaccine(live)....................................902Foams,

Felypressin.......................................................................................1999Foams,intrauterine.........................................................................

Foams,medicated............................................................................715

rectal.....................................................................................733712

FenbendazoleFenbufen..........................................................................................2001forveterinaryuse................................................2000Foams,

Fennel,bitter...................................................................................1124Folicvaginal..................................................................................740

Folinate,acid..........................................................................................2065calcium............................................................................1552Fennel,Fenofibrate......................................................................................2002sweet............................................................................7.1-3361Foot-and-mouth

Fenoterolhydrobromide........................................................7.1-3415ForeignForeignestersdisease(ruminants)vaccine(inactivated)....904

matterin(2.8.2.)....................................................................239essentialoils(2.8.6.)........................................239

Fentanyl...........................................................................................2005FentanylForeignoilsinfattyoilsbythin-layerchromatographyFenticonazolecitrate...............................................................................2006nitrate....................................................................2007Formaldehyde,(2.4.21.)............................................................................................free(2.4.18.)..........................................................119118Fenugreek........................................................................................1126Fermentation,Formaldehyde

Ferricchlorideproductshexahydrate........................................................2008of.............................................................685Formoterolsolution(35percent)........................................2066

Foscarnetsodiumfumaratehexahydrate...................................................2069dihydrate..................................................2067

FerrousFerrousfumarate...........................................................................2009Fosfomycin

Ferrousgluconate..........................................................................sulfate,dried.............................................................7.2-36532010Fosfomycincalcium................................................................

Fosfomycinsodium.................................................................7.3-3933

trometamol................................................................20727.3-3934

FerrousFeverfew...........................................................................................1126sulfateheptahydrate...............................................7.2-3653Fosinopril

Fexofenadinehydrochloride........................................................2013Fourstamensodium..........................................................................2073

Fowlcholerastephaniavaccine(inactivated)...............................................905root..........................................................1127

Fibrinogen,FibrinFowl-pox

Filgrastimsealanthuman........................................................................

concentratedkit............................................................................2174

solution...............................................20142015Framycetinvaccine(live)....................................................................906

Frangulabark..........................................................................sulfate.........................................................................20767.1-3362Films,Finasteride.......................................................................................orodispersible..............................................................7.4-4259Frangula

Fineness,powder(2.9.35.).............................................................3082018Frankincense,barkdryextract,standardised..................................1129

FreeformaldehydeIndian....................................................................1152(2.4.18.)...........................................................118FishFlavoxateoil,richinomega-3acids.....................................................2019Freezing

Flecainidehydrochloride...............................................................2021acetate...................................................................7.1-3416Freshpoint(2.2.18.)....................................................................34

Friabilitybilberryofgranulesfruitdryandextract,spheroidsrefined(2.9.41.)...................andstandardised...11307.4-4103Flocculationvalue(Lf)Friability

Flowabilitytoxoids(Ramonofdiphtheriaandtetanustoxinsand

(2.9.16.).........................................................................272assay)(2.7.27.)..................................................231Friabilityof

Fructose...........................................................................................2077ofuncoateduncoatedtabletstablets(2.9.7.)...........................................266(2.9.7.)(5.8.).......................7.1-3346

FlowFlubendazole..................................................................................2024cytometry(2.7.24.).................................................................229Fucus................................................................................................Flucloxacillinmagnesiumoctahydrate.....................................2025Fulvestrant...............................................................................Fumitory..........................................................................................11327.3-39351161FlucloxacillinFluconazole.....................................................................................2028sodium....................................................................2026Functionalgroupsandions,identificationreactionsofFlucytosine......................................................................................2029Furosemide......................................................................................2078(2.3.1.)...............................................................................................107FludarabineFludeoxyglucosephosphate.................................................................2031(18Furunculosisvaccine(inactivated,oil-adjuvanted,injectable)

Fludrocortisoneacetate................................................................2033F)injection....................................................969Fusidate,salmonids.........................................................................................907for

sodium.....................................................................7.3-4006Flumazenil.......................................................................................2035Fusidicacid..............................................................................7.3-3936Flumazenil(N-[11

Flumequine.....................................................................................2036C]methyl)injection...........................................972

FlumetasoneG

FlunarizineGabapentin...............................................................................Flunitrazepam.................................................................................2039dihydrochloride........................................................2038pivalate....................................................................2037

Galactose..........................................................................................20837.2-3661

FlunixinGalantamine

Fluocinolonemeglumineforveterinaryuse.....................................2040Gallium(67hydrobromide.........................................................2083

Fluocortoloneacetonide................................................................2041pivalate..................................................................2042Ganciclovir.......................................................................................2086Ga)citrateinjection.....................................................975Fluorescein......................................................................................2044Gargles.......................................................................................FluoresceinGarlic7.4-4257Fluoride(18F)sodium.......................................................................2045solutionforradiolabelling....................................973Garlicforpowder..................................................................................1133homoeopathicpreparations......................................1290FluoridesGas

Fluorimetry(2.4.5.)...............................................................................114Gasadsorption,

Fluorodopa((2.2.21.).........................................................................18F)(preparedbyelectrophilicsubstitution)35Gasadsorption,chromatographyspecificspecific

(2.2.28.).........................................................surfacesurfaceareaareabyby(2.9.26.)(2.9.26.).....................(5.8.)..7.1-3347291

43Gas

Fluorouracil.....................................................................................2046injection...........................................................................................974Gases,detectorcarbontubesdioxide(2.1.6.)................................................................17in(2.5.24.).................................................143GeneralNotices(1)applytoallmonographsandothertexts4413

欧洲药典7.4索引(现行版)

Indexhttp://www.77cn.com.cn/forum.php?mod=viewthread&tid=21456&fromuid=1023 EUROPEANPHARMACOPOEIA

7.4Gases,GranisetronGases,carbonnitrogenmonoxidemonoxideinand(2.5.25.)............................................nitrogendioxidein(2.5.26.)..144145Granules.............................................................................................hydrochloride...........................................................2124713Gases,GranulesGases,nitrousoxidein(2.5.35.)....................................................Granulesandpowdersfororal

Gases,oxygenwaterinin(2.5.28.)..................................................................(2.5.27.)...............................................................150145145Granulesandandpowdersspheroids,forfriabilitysyrups.................................................solutionsandsuspensions....718

of(2.9.41.)...................7.4-4103719

Gas-gangreneGranules,Gas-gangreneantitoxin,Granules,coated...............................................................................714Gas-gangreneantitoxinantitoxin(novyi).....................................................950mixed......................................................950

(perfringens)..........................................951Granules,effervescent.....................................................................gastro-resistant...............................................................714714Gas-gangreneGranules,GasGreatermodified-release.............................................................714

Gastro-resistantpycnometricantitoxin(septicum)...............................................952

capsules................................................................708densityofsolids(2.9.23.)................................288Griseofulvin.....................................................................................2126celandine...........................................................................1145

Gastro-resistantGuaiacol...........................................................................................2127Gastro-resistantgranules................................................................714Guaifenesin......................................................................................2128Gelatin..............................................................................................2087tablets...................................................................738Guanethidinemonosulfate...........................................................2129Gels......................................................................................................735Guar..................................................................................................GelsGuar1146Gemcitabineforinjections............................................................................725hydrochloride..........................................................2088Guidelinesgalactomannan.....................................................................2130forusingthetestforbacterialendotoxinsGemfibrozil......................................................................................2090GeneralGuidelines(5.1.10.)............................................................................................520forusingthetestforsterility(5.1.9.)......................519Generalnoticestextson(1.).................................................................biologicalproducts(5.2.)................................5277.4-4083

GeneralGenetextsonmicrobiology(5.1.)............................................503H

Gentamicintransfersulfate..................................................................medicinalproductsforhumanuse(5.14.)........6477.4-4315Haemagglutinins,anti-Aandanti-B(2.6.20.)....................7.2-3545GentianHaematopoieticproducts,numerationofCD34/CD45+cellsGentianroot....................................................................................1133

Gestodene........................................................................................2092tincture.............................................................................1134Haematopoietic(2.7.23.)............................................................................................228in

progenitorcells,human,colony-formingcell

Ginger...............................................................................................1135GingivalHaematopoieticassayfor(2.7.28.)...........................................................................232Ginkgodrysolutions...................................................................extract,refinedandquantified..............................11367.4-4257Haemodiafiltrationstemandcells,haemofiltration,human............................................solutionsfor..........21382175GinkgoHaemodialysis,

Ginseng.............................................................................................leaf......................................................................................1138Haemodialysis

Glasscontainersforpharmaceuticaluse(3.2.1.)......................3631140Haemodialysis,solutions,concentrated

solutionsconcentrated,solutionsfor..............................2136

for........................................................2136waterfordiluting..2135

Glibenclamide.................................................................................2094Haemofiltration

Gliclazide..........................................................................................2096Haemophilusandhaemodiafiltration,solutionsfor..........2138Glimepiride......................................................................................2097pertussis(acellular,typeb(conjugate),component)diphtheria,vaccine(adsorbed).............758tetanusandGlipizide...........................................................................................2098Haemophilus

Glossary(acellular,typeb(conjugate),diphtheria,tetanus,

Glucagon,(dosagehuman...........................................................................forms).................................................................7072100(adsorbed)http://www.77cn.com.cnponent)andpoliomyelitis(inactivated)pertussisvaccine768Glucoheptonate,Haemophilus

Glucosamine(acellular,

Glucosaminehydrochloride..................................................calcium..............................................................1554

sulfatesodiumchloride................................7.37.3-3945-3946(inactivated)component),typeb(conjugate),diphtheria,tetanus,pertussis

vaccine(adsorbed).................................................hepatitisB(rDNA)andpoliomyelitis765

Glucose,Haemophilus

Glucose,anhydrous.......................................................................pertussis

Glucose,liquid................................................................................2102

liquid,spray-dried..........................................................21032103(adsorbed)...............................................................................(wholetypecell)b(conjugate),andpoliomyelitisdiphtheria,(inactivated)tetanus,vaccine7.2-3572GlucoseHaemophilus

Glutamicmonohydrate...................................................................2104Haemorrhagictype

Glutathione......................................................................................acid..................................................................................21052106Halofantrinehydrochloride.........................................................diseasebconjugatevaccine(inactivated),vaccine.......................................rabbit.................933776

2141

GlycanHaloperidol......................................................................................Glycerol............................................................................................analysisofglycoproteins(2.2.59.).....................................97Haloperidol

Glycerol(85percent)....................................................................21082109Halothane........................................................................................decanoate...........................................................7.2-36652142

2144

GlycerolHamamelis

Glyceroldibehenate................................................................7.4-4317Hard

Glyceroldistearate.........................................................................formal........................................................................7.3-39472111Hardcapsules....................................................................................708leaf...............................................................................1146

fat............................................................................................2146

GlycerolHard

Glycerolmonocaprylate................................................................2112Harmonisation,paraffin...................................................................................2668Glycerolmonocaprylocaprate......................................................monolinoleate.................................................................21132114Hawthornberries...........................................................................pharmacopoeial(5.8.)...............................7.1-33451147GlycerolHawthorn

Glycerolmono-oleate.....................................................................2115Hawthornleafandflower............................................................1148Glycerolmonostearatetriacetate..........................................................................312740-55.......................................................2116Hawthornleafleafandandflowerflowerdryliquidextract.......................................extract,quantified..............11501149GlycerylHeavy

Glycine..............................................................................................trinitratesolution...........................................................2117Heavybismuthsubnitrate............................................................1498

Glycoproteins,glycananalysisof(2.2.59.)....................................211897Heavykaolin....................................................................................magnesiumcarbonate......................................................24092314GlycopyrroniumHeavy

Glycyrrhizatebromide......................................................7.1-3423Heavymagnesiumoxide...............................................................2415Goldenrod........................................................................................ammonium.............................................................13841141Heavymetalsmetals(2.4.8.)........................................................................114inherbaldrugsandfattyoils(2.4.27.)...............129Goldenrod,Hedera

GoldensealEuropean....................................................................1142Helium..............................................................................................helixforhomoeopathicpreparations..........................1291Gonadorelinrhizome.......................................................................acetate......................................................................11432119Heparin,assayof(2.7.5.)................................................................2082146Gonadotrophin,Heparin

Gonadotrophin,chorionic............................................................2120Heparincalcium.............................................................................2147Goserelin..........................................................................................equineserum,forveterinaryuse..................21212121Heparins,inlow-molecular-mass.....................................................coagulationfactors,assayof(2.7.12.).....................2202151GraftedHeparin

Gramicidin.......................................................................................2123copolymer,macrogolpoly(vinylalcohol)...................2401Hepatitissodium..............................................................................Aimmunoglobulin,human........................................214921764414Seetheinformationsectionongeneralmonographs(coverpages)

欧洲药典7.4索引(现行版)

EUROPEANPHARMACOPOEIAhttp://www.77cn.com.cn/forum.php?mod=viewthread&tid=21456&fromuid=1023 7.4

IndexHepatitisHomoeopathicvaccine.....................................................................................A(inactivated,adsorbed)andtyphoidpolysaccharide7.3-3834Homoeopathicpreparations,preparations,orientalpillulesfor...........................cashewfor...................12957.4-4271HepatitisA(inactivated)andhepatitisB(rDNA)vaccineHomoeopathicpreparations,potassium

Hepatitis(adsorbed)........................................................................................779Avaccine,assayof(2.7.14.)..........................................222Homoeopathicfor.............................................................................................dichromate

preparations,saffronfor...................................12967.1-3371

HepatitisHomoeopathicpreparations,sodiumHepatitisA

HepatitisAvaccine(inactivated,adsorbed)...............................780

Bvaccineimmunoglobulin(inactivated,forvirosome)...............................intravenousadministration,781Homoeopathicdihydratefor..........................................................................tetrachloroaurate

preparations,sulfurfor..............................7.17.1-3372-3372Homoeopathicstocks(methodsofpreparationHepatitishuman.....................................................................................

HepatitisBBimmunoglobulin,(rDNA),diphtheriahuman........................................7.3-3953

andtetanusvaccine2176Honey...............................................................................................potentisation..........................................................................of)and7.2-35922163HoneyHepatitis(adsorbed)........................................................................................753Hopbeeforhomoeopathic

component)B(rDNA),vaccinediphtheria,(adsorbed)..................................................tetanusandpertussis(acellular,760Humanstrobile.....................................................................................preparations..............................1292

α-1-proteinaseinhibitor.................................................11512184HepatitisHumanalbumininjection,iodinated(125

component),B(rDNA),diphtheria,tetanus,pertussis(acellular,

typebconjugatepoliomyelitisvaccine(adsorbed).........................................(inactivated)andhaemophilus765HumanI)..................................976

Humanalbuminanti-Dimmunoglobulin..................................................solution.............................................................21652166HepatitisHepatitisBvaccine(rDNA)...................................................7.2-3574Human

HepatitisBCvaccinevirus(HCV),(rDNA),validationassayofof(2.7.15.)..................nucleicacidamplification7.3-3794Humananti-Dimmunoglobulin,assay

administration..............................................................................anti-Dimmunoglobulinforintravenousof(2.7.13.)...................220

2167techniquesforthedetectionofHCVRNAinplasmaHuman

Heptaminolguidelines........................................................................................pools:

hydrochloride...........................................................2153181HumanantithrombinIII,assayof(2.7.17.).................................224

HumanantithrombincoagulationfactorIIIconcentrate.................................II,assayof(2.7.18.).........................2247.3-3952

HerbalHerbaldrugHuman

Herbaldrugs............................................................................preparations...............................................................676

drugsandfattyoils,heavymetalsin(2.4.27.)..............7.3-3815129HumancoagulationfactorIX......................................................2172

HumancoagulationcoagulationfactorfactorIX,VII....................................................assayof(2.7.11.)........................2169219

HerbalHerbaldrugs,determinationofaflatoxinHuman

(2.8.12.)............................................................................................drugs,determinationofessentialBoils1inin(2.8.18.).........244herbaldrugs241HumancoagulationfactorVII,assayof(2.7.10.)......................219

HumancoagulationcoagulationfactorfactorVIII...................................................VIII,assayof(2.7.4.).......................2072170

HerbalHerbaldrugs,Human

Herbaldrugsdeterminationoftannins(2.8.14.).....................243

drugs,formicroscopichomoeopathicexaminationpreparations..................of(2.8.23).................2507.3-3883Humancoagulation

Humancoagulationfactor

coagulationfactorVIII

factorX,XI......................................................assay(rDNA).....................................of(2.7.19.).........................2252171

2173HerbalHerbaldrugs:Human

Herbaldrugs,medicinaltestsampling

productsforaristolochicandsamplepreparation(2.8.20.).....246

fororalacidsuse,inmicrobial(2.8.21).................247examinationHumancoagulationfactorXI,assay

Humanfibrinogen..........................................................................of(2.7.22.).......................227

haematopoieticprogenitorcells,colony-formingcell2174

Herbal(2.6.31.)............................................................................................

(5.1.8.)...............................................................................................medicinalproductsfororaluse,microbiologicalquality197

519Humanassayfor

Humanhaematopoietic(2.7.28.)...........................................................................232

hepatitisAimmunoglobulin.........................................stemcells.............................................21752176HerbalHerbalpreparations.........................................................................676Human

Herbalsubstances...................................................................teas.........................................................................................6777.3-3815Humanhepatitis

administration.......................................................................hepatitisBBimmunoglobulin.........................................immunoglobulinforintravenous2176

7.3-3953HerpesHexamidinezoster(shingles)vaccine(live)........................................828Human

Hexetidine........................................................................................2155diisetionate...............................................................2154Humaninsulin................................................................................2241

Humanmeaslesnormalimmunoglobulin.........................................immunoglobulin...............................................7.2-36662177

Hexobarbital....................................................................................2156HexosaminesHuman

Hexylresorcinol...............................................................................2157inpolysaccharidevaccines(2.5.20.)...................142Humanadministration.......................................................................normalimmunoglobulinforintravenous

papillomavirusvaccine(rDNA).............................7.27.2-3668-3575HighlyHistaminepurifiedHuman

Histamine(2.6.10.)...........................................................................water....................................................................3222

dihydrochloride..........................................................2158162Humanplasmafor

Humanplasmaplasmin(pooledfractionation.................................................

inhibitor,andassaytreatedof(2.7.25.)...............................230forvirusinactivation)..21812182

HistamineHistidine...........................................................................................2159phosphate....................................................................2159Human

Histidinehydrochloridemonohydrate......................................2160HumanproteinC,assayof(2.7.30.).............................................234

HumanproteinprothrombinS,assaycomplex.....................................................of(2.7.31.).............................................2352185HomatropineHomatropinehydrobromide........................................................2161Human

Homeopathicmethylbromide...............................................preparations,hydrastiscanadensisfor.....7.37.3-3951-3884Humanrabies

Humanrubellaimmunoglobulin..................................................2186

tetanusimmunoglobulin................................................immunoglobulin........................................7.2-36702187

HomoeopathicHomoeopathicpillules,impregnated..................................7.4-4271Human

Homoeopathicpreparations.................................................preparations,arsenioustrioxidefor..............12867.2-3591Humanvaricellaimmunoglobulin..............................................2188

administration..............................................................................varicellaimmunoglobulinforintravenous2189Homoeopathicpreparations,calciumiodidetetrahydrateHuman

Homoeopathicfor....................................................................................................1288preparations,commonstingingnettlefor....1288Humanvon

Hyaluronate,vonWillebrandWillebrandfactor.....................................................

sodium.....................................................................2927factor,assayof(2.7.21.)......................2262189

Homoeopathicpreparations,copperacetatemonohydrateHyaluronidase

Homoeopathicfor....................................................................................................1289preparations,copperfor...................................1289Hydralazine................................................................................

Hydrastiscanadensishydrochloride..........................................................2190

forhomoeopathicpreparations....7.3-38842191

HomoeopathicHomoeopathicpreparations,Hydrochloric

Homoeopathicpreparations,garlic

preparations,hederafor.....................................1290

herbaldrugshelixfor.........................1291for.................7.3-3883Hydrochloricacid,

Hydrochlorothiazide...............................................................acid,concentrated................................................dilute..............................................................2192

7.4-43212192

HomoeopathicHomoeopathicpreparations,honeyHydrocodone

Homoeopathicpreparations,preparations,hyoscyamusbeefor.............................1292

hypericumfor............................1293for.........................1292Hydrocortisone...............................................................................hydrogentartrate2.5-hydrate...........................2194

Hydrocortisoneacetate.................................................................21962198HomoeopathicHomoeopathicpreparations,preparations,ironmotherfor........................................1294tincturesfor..........7.3-3884HydrocortisoneHydrogenatedarachishydrogenoil.............................................................succinate..........................................22001413

GeneralNotices(1)applytoallmonographsandothertexts4415

欧洲药典7.4索引(现行版)

Indexhttp://www.77cn.com.cn/forum.php?mod=viewthread&tid=21456&fromuid=1023 EUROPEANPHARMACOPOEIA

7.4HydrogenatedImmunoglobulin,Hydrogenatedcastorcottonseedoil...............................................................1596oil......................................................1769Immunoglobulin,humanhumantetanus........................................varicella.............................................7.2-36702188HydrogenatedImmunoglobulin,Hydrogenatedsoya-beanoil.........................................................2968

Hydrogenatedvegetablewoolfat...........................................................oils,nickelin(2.4.31.)........................7.4-4396132Immunoglobulin,(2.6.17.).............................................................................................testforanticomplementaryactivityof

testforFcfunctionof(2.7.9.)........................217177

HydrogenImmunologicalHydrogenperoxidesolution(30percent)...............................2202

Hydromorphoneperoxidehydrochloride..................................................2202solution(3percent)..................................2201Immunoseraanimaloriginandforveterinary

vaccines,theproductionmedicinalproducts,substancesof

phenolofin(5.2.5.).............................535(2.5.15.)...........................141HydrophobicImmunoseraandvaccines,veterinary,evaluationofefficacyofHydrouscolloidalsilica........................................................2903

Hydroxocobalaminwoolfat.....................................................................acetate...........................................................22037.4-4397Immunosera(5.2.7.)...............................................................................................538andvaccines,veterinary,evaluationofsafetyHydroxocobalaminHydroxocobalaminchloride.........................................................2204Immunosera(5.2.6.)..............................................................................................536Hydroxycarbamide.........................................................................2206sulfate...........................................................2205ofeachbatchand(5.2.9.).....................................................................547vaccines,veterinary,evaluationofthesafetyHydroxyethylcellulose...................................................................2208ImmunoseraHydroxyethylmethylcellulose......................................................2476Immunoseraforhumanuse,animal............................................678Hydroxyethylsalicylate.................................................................2207Implants.............................................................................................725forveterinaryuse.....................................................680HydroxyethylImpuritiesinsubstancesforpharmaceuticaluse,controlHydroxylstarches...................................................................2984

Hydroxypropylbetadex...........................................................value(2.5.3.)....................................................................7.3-3953137Indapamide......................................................................................2232(5.10.).......................................................................................7.4of-4247Hydroxypropylcellulose................................................................IndianHydroxypropylmethylcellulose....................................................2211Indicators,frankincense.......................................................................1152Hydroxypropylmethylcellulosephthalate.................................22212219(2.2.4.)................................................................................................relationshipbetweenapproximatepHandcolour25HydroxypropylIndinavirHydroxyzinestarch....................................................................2981Indium(111sulfate.............................................................................2233

Hymecromone.................................................................................2213hydrochloride.........................................................2212

Hyoscine...........................................................................................Indium(111In)In)chlorideoxinesolution.........................................................978solution....................................................977Hyoscine2214Indium

Hyoscinebutylbromide.................................................................2215hydrobromide................................................................2216Indometacin....................................................................................2235(111In)pentetateinjection.................................................979HyoscyamineInductivelycoupledplasma-atomicemissionspectrometryHyoscyamusHypericum.......................................................................................1241forsulfate......................................................................homoeopathicpreparations..........................12922217Inductively(2.2.57.)..............................................................................................HypericumInfectiousbovinecoupledrhinotracheitisplasma-massspectrometryvaccine(live).........................908(2.2.58.)..........9496Hypromellose..................................................................................forhomoeopathicpreparations.............................1293Infectious

Hypromellosephthalate...............................................................22212219Infectiousbronchitisvaccine

Infectiousbronchitisbursaldiseasevaccine(inactivated),

vaccine(live),(inactivated),avian...................................852avian.....................851

avian..............854Infectious

IInfectiousbursaldisease

Ibuprofen.........................................................................................2225Infectiouschickenencephalomyelitisanaemiavaccinevaccine(live),

vaccine(live)..................................avian...........................856

(live),avian....................857910

IcelandInfectious

ICH(5.8.)...................................................................................moss....................................................................................11527.1-3345Influenzalaryngotracheitisvaccine(live),

Ichthammol.....................................................................................2227Influenzavaccinevaccine(split(surfacevirion,antigen,inactivated)...............................788avian......................859

inactivated).......................789

IdentificationInfluenzavaccine(surfaceantigen,inactivated,preparedIdentification(2.3.)..........................................................................andcontrolofresidualsolvents(2.4.24.)..7.2-3537107

IdentificationoffattyoilsbyInfluenzacultures)...........................................................................................incell

vaccine(surfaceantigen,inactivated,virosome)....793791

Influenza

Identification(2.3.2.)..............................................................................................thin-layerchromatography

ofphenothiazinesbythin-layerchromatography110Influenzavaccine

cultures)...........................................................................................796vaccine(whole(wholevirion,virion,inactivated)............................795inactivated,preparedincell

Identification(2.3.3.)..............................................................................................Infrared

(2.3.1.)...............................................................................................reactionsofionsandfunctionalgroups110

107Infusions............................................................................................725absorptionspectrophotometry(2.2.24.).......................38

Idoxuridine......................................................................................2227Inhalationgas,krypton(81mKr).....................................................983Ifosfamide........................................................................................2228Inhalation

Imipenem.........................................................................................2230Inhalation,powders.................................................................ImipramineInhalation,preparationspreparationsfor..................................................7.3

for:aerodynamicassessmentof7.3-3828

fine-3825

Immunochemicalhydrochloride...........................................................2231

Immunoglobulinformethodshuman(2.7.1.)http://www.77cn.com.cne,anti-Tlymphocyte,201Injectableparticles(2.9.18.)...........................................................................

Injections...........................................................................................724insulinpreparations...................................................2249274

Immunoglobulinanimal.............................................................................................1404Injections,

anti-D..............................................................................................forintravenousadministration,human2167Injectionsgels

ImmunoglobulinInjectionsororinfusions,for............................................................................725

infusions,concentratespowdersfor............................................725for....................................725

Inositol,

ImmunoglobulinhepatitisB..............................................................................forintravenousadministration,human

forintravenousadministration,human7.3-3953Inserts,myo-..................................................................................2236

Insulinaspart..................................................................................2237ophthalmic..........................................................................712

Immunoglobulinnormal.....................................................................................7.2Insulin,

varicella..........................................................................................forintravenousadministration,human-3668

2189Insulin,bovine................................................................................2239

Immunoglobulin,Insulininjection,human................................................................................2241biphasic............................................................2243Immunoglobulin,humanInsulin

Immunoglobulin,humananti-D.................................................

humananti-D,hepatitisassayA.........................................of(2.7.13.)...................2202166

2176Insulininjection,biphasicisophane..........................................2244

Immunoglobulin,Insulininjection,injection,isophane...........................................................2244soluble..............................................................2244Immunoglobulin,humanhepatitisInsulin

Immunoglobulin,humanB........................................2176

humanmeasles..............................................normal........................................7.2-36662177Insulin,lispro...................................................................................2245

Immunoglobulin,Insulinpreparations,porcine...............................................................................2247injectable..................................................2249Immunoglobulin,humanhumanrabies.................................................rubella...............................................21862187InsulinInsulinzinczincinjectableinjectablesuspension.............................................2251suspension(amorphous)....................22524416Seetheinformationsectionongeneralmonographs(coverpages)

欧洲药典7.4索引(现行版)

EUROPEANPHARMACOPOEIAhttp://www.77cn.com.cn/forum.php?mod=viewthread&tid=21456&fromuid=1023 7.4

IndexInsulinInterferonzincalfa-2injectableconcentratedsuspensionsolution....................................2252(crystalline)......................2252J

InterferonJavanese

Interferonbeta-1aconcentratedsolution.................................2255Javatea.............................................................................................1158turmeric..........................................................................1257Interferons,gamma-1bassayof(5.6.)..............................................................607concentratedsolution...........................2257Josamycin.........................................................................................2305InternationalJosamycin

IntramammarySystemJuniper.......................................................................................propionate....................................................................23077.2-3585Intraruminaldevices.......................................................................preparations(SI)unitsfor(1.)....................................veterinaryuse........................7.4-4083714715Juniperoil........................................................................................1160IntrauterineIntrauterinecapsules......................................................................715K

Intrauterinefoams...........................................................................preparationsforveterinaryuse.............................715715Kanamycin

IntrauterineKanamycinacidmonosulfate...............................................................sulfate.................................................................23132313Intrauterinesolutions,suspensions.............................................715Kaolin,

Intrauterinesticks............................................................................tablets..........................................................................715715Kelp...................................................................................................heavy...................................................................................2314Intrinsicdissolution(2.9.29.)........................................................294Ketaminehydrochloride........................................................7.2-36751161InKetobemidone

Iobenguanevivoassay(123ofKetoconazole..................................................................................hydrochloride......................................................2316

131I)poliomyelitisinjection.............................................................979vaccine(inactivated)(2.7.20.)..225IobenguaneKetoprofen.......................................................................................23172318

Iobenguane(Ketorolac

Iobenguane(131I)

sulfateI)injectioninjectionfordiagnosticuse...........................980

forradiopharmaceuticalfortherapeuticuse.........................preparations....982981Ketotifen

IodinatedKnotgrass.........................................................................................hydrogentrometamol...................................................................2320fumarate......................................................23211162Iodinated(125I)Krypton(81m

Iodine................................................................................................2261povidone........................................................................2778humanalbumininjection...................................976

Kudzuvineroot........................................................................Kr)inhalationgas......................................................9837.3-3867

IodineIodixanol..........................................................................................2261value(2.5.4.).........................................................................137L

Iodomethylnorcholesterol(131I)injection...................................982Labetalolhydrochloride...............................................................2327Iohexol..............................................................................................2264Lactic

IonicLacticacid........................................................................................2328

ion-selectiveconcentration,electrodespotentiometric(2.2.36.)...................................................determinationofusing57Lactitolacid,monohydrate....................................................................2329(S)-...............................................................................2328Ionsandfunctionalgroups,identificationLactobionicLactose,

Ion-selective(2.3.1.)...............................................................................................reactionsof

electrodes,potentiometricdeterminationofionic107Lactosemonohydrate....................................................................2333anhydrous.................................................................acid.............................................................................23317.3-3959

Lactulose..........................................................................................2334

Iopamidol.........................................................................................2266concentration(2.2.36.)...................................................................57Lactulose,

Iopanoicacid...................................................................................2268Lamivudine...............................................................................liquid.............................................................................23367.3-3960Iopromide.........................................................................................2269Lamotrigine.....................................................................................2339IotalamicLansoprazole...................................................................................2341Iotrolan.............................................................................................2273acid..................................................................................2272Laserlightdiffraction,particlesizeanalysisby(2.9.31.).......295IoxaglicLaurilsulfate,

Ipecacuanhaacid....................................................................................2275Lauromacrogolsodium....................................................................2933Ipecacuanha,liquidprepared..................................................................1154extract,standardised.................................1153Lauroylmacrogolglycerides........................................................2344400.......................................................................2342IpecacuanhaLavender

Ipecacuanharoot...........................................................................1155Lavenderflower.......................................................................7.1-3363Ipratropiumbromide.....................................................................2277tincture,standardised...........................................1156Lavenderoil.....................................................................................oil,spike.........................................................................12401164Irbesartan........................................................................................2278Lead

IronLeflunomide....................................................................................2345insugars(2.4.10.)...................................................................117Iron(2.4.9.).........................................................................................117forhomoeopathicpreparations.........................................1294Lemonoil.........................................................................................1165Irrigation,Lemon

IsatisLeptospirosisverbenaleaf................................................................7.3Isoconazole......................................................................................2279root..................................................................................preparationsfor............................................................7.3-3866731

Leptospirosisvaccine-3868

vaccine(inactivated),(inactivated),bovine................................862canine................................874

IsoconazoleLetrozole..........................................................................................2347Isoelectricnitrate........................................................................2281Leucine.............................................................................................2348Isoelectricfocusingfocusing(2.2.54.)............................................................(2.2.54.)(5.8.)......................................7.1-334583Leuprorelin......................................................................................2348Isoflurane.........................................................................................2282Levamisole

Isoleucine.........................................................................................2283Levamisoleforveterinaryuse.....................................................2350Isomalt..............................................................................................2284Levetiracetam..........................................................................hydrochloride............................................................23517.3-3962Isoniazid...........................................................................................2285Levocabastine

IsophaneLevocarnitine..................................................................................2355hydrochloride......................................................2354Isoprenalineinsulinhydrochloride..........................................................2286injection............................................................2244Levodopa..........................................................................................2356IsoprenalineLevodropropizine...........................................................................2358Isopropylsulfate.......................................................................2287Levofolinate

Isopropylalcohol............................................................................2287myristate........................................................................2288Levomenthol...................................................................................2359pentahydrate,calcium...........................................1563IsopropylLevomepromazine

Isosorbidepalmitate........................................................................2289Levomepromazinehydrochloride...............................................2360Isosorbidedinitrate,mononitrate,diluteddiluted.......................................................2289................................................2291Levomethadonehydrochloride...................................................2362maleate..........................................................2361Isotretinoin......................................................................................2293Levonorgestrel.........................................................................IsoxsuprineLevothyroxine7.4-4325Ispaghulahusk...............................................................................1156hydrochloride...........................................................2294Levulinatedihydrate,sodium...........................................................calcium.....................................................15657.3-3964IspaghulaLidocaine.........................................................................................2365Isradipine.........................................................................................2296seed................................................................................1157Lidocaine

Itraconazole....................................................................................2297Lightliquidhydrochloride...............................................................2366paraffin......................................................................2669Ivermectin........................................................................................2299Light

Ivyleaf..............................................................................................1157Lightmagnesiummagnesiumcarbonate........................................................2409oxide................................................................2416GeneralNotices(1)applytoallmonographsandothertexts4417

本文来源:https://www.bwwdw.com/article/ce3i.html

Top